Premier (PINC) 10-Q 2 May 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Mar. 31, 2023	Apr. 27, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-36092
Entity Registrant Name	Premier, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	35-2477140
Entity Address, Address Line One	13034 Ballantyne Corporate Place
Entity Address, City or Town	Charlotte,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28277
City Area Code	704
Local Phone Number	357-0022
Title of 12(b) Security	Class A Common Stock, $0.01 Par Value
Trading Symbol	PINC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		119,078,357
Entity Central Index Key	0001577916
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Assets
Cash and cash equivalents	$ 91,493	$ 86,143
Accounts receivable (net of $2,747 and $2,043 allowance for credit losses, respectively)	115,289	114,129
Contract assets (net of $808 and $755 allowance for credit losses, respectively)	290,824	260,061
Inventory	94,431	119,652
Prepaid expenses and other current assets	59,091	65,581
Total current assets	651,128	645,566
Property and equipment (net of $642,684 and $578,644 accumulated depreciation, respectively)	206,687	213,379
Intangible assets (net of $252,997 and $217,582 accumulated amortization, respectively)	442,718	356,572
Goodwill	1,069,073	999,913
Deferred income tax assets	722,949	725,032
Deferred compensation plan assets	47,699	47,436
Investments in unconsolidated affiliates	230,300	215,545
Operating lease right-of-use assets	31,658	39,530
Other assets	110,305	114,154
Total assets	3,512,517	3,357,127
Liabilities and stockholders' equity
Accounts payable	53,486	44,631
Accrued expenses	63,372	40,968
Revenue share obligations	258,112	245,395
Accrued compensation and benefits	59,088	93,638
Deferred revenue	27,880	30,463
Current portion of notes payable to former limited partners	99,200	97,806
Line of credit and current portion of long-term debt	236,272	153,053
Other current liabilities	102,922	47,183
Total current liabilities	900,332	753,137
Long-term debt, less current portion	1,008	2,280
Notes payable to former limited partners, less current portion	126,614	201,188
Deferred compensation plan obligations	47,699	47,436
Deferred consideration, less current portion	29,189	28,702
Operating lease liabilities, less current portion	25,468	32,960
Other liabilities	46,416	42,574
Total liabilities	1,176,726	1,108,277
Commitments and contingencies (Note 13)
Stockholders' equity:
Class A common stock, $0.01 par value, 500,000,000 shares authorized; 125,309,682 shares issued and 118,880,307 shares outstanding at March 31, 2023 and 124,481,610 shares issued and 118,052,235 shares outstanding at June 30, 2022	1,253	1,245
Treasury stock, at cost; 6,429,375 shares at both March 31, 2023 and June 30, 2022	(250,129)	(250,129)
Additional paid-in capital	2,175,048	2,166,047
Retained earnings	409,630	331,690
Accumulated other comprehensive loss	(11)	(3)
Total stockholders' equity	2,335,791	2,248,850
Total liabilities and stockholders' equity	$ 3,512,517	$ 3,357,127

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Allowance for doubtful accounts	$ 2,747	$ 2,043
Allowance for credit losses	808	755
Accumulated depreciation	642,684	578,644
Accumulated amortization	$ 252,997	$ 217,582
Treasury stock, shares (in shares)	6,429,375	6,429,375
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	125,309,682	124,481,610
Common stock outstanding (in shares)	118,880,307	118,052,235

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Net revenue:
Net revenue	$ 322,232	$ 347,833	$ 995,731	$ 1,092,195
Cost of revenue:
Cost of revenue	103,162	135,356	331,935	431,242
Gross profit	219,070	212,477	663,796	660,953
Operating expenses:
Selling, general and administrative	143,587	143,676	416,165	418,330
Research and development	1,001	826	2,976	2,666
Amortization of purchased intangible assets	11,916	11,151	35,415	32,890
Operating expenses	156,504	155,653	454,556	453,886
Operating income	62,566	56,824	209,240	207,067
Equity in net income of unconsolidated affiliates	4,630	3,991	14,547	17,165
Interest expense, net	(4,269)	(2,804)	(11,759)	(8,465)
Gain on FFF Put and Call Rights	0	0	0	64,110
Other income (expense), net	2,954	(4,248)	3,720	(2,176)
Other income (expense), net	3,315	(3,061)	6,508	70,634
Income before income taxes	65,881	53,763	215,748	277,701
Income tax expense	17,232	14,694	59,766	40,094
Net income	48,649	39,069	155,982	237,607
Net income attributable to non-controlling interest	(1,848)	(654)	(2,419)	(1,643)
Net income attributable to stockholders	46,801	38,415	153,563	235,964
Comprehensive income:
Net income	48,649	39,069	155,982	237,607
Comprehensive income attributable to non-controlling interest	(1,848)	(654)	(2,419)	(1,643)
Foreign currency translation gain (loss)	1	4	(8)	3
Comprehensive income attributable to stockholders	$ 46,802	$ 38,419	$ 153,555	$ 235,967
Weighted average shares outstanding:
Basic (in shares)	118,872	118,697	118,668	120,957
Diluted (in shares)	119,816	119,813	119,832	122,302
Earnings per share attributable to stockholders:
Basic (in dollars per share)	$ 0.39	$ 0.32	$ 1.29	$ 1.95
Diluted (in dollars per share)	$ 0.39	$ 0.32	$ 1.28	$ 1.94
Services and software licenses
Net revenue:
Net revenue	$ 265,020	$ 254,204	$ 812,665	$ 768,370
Cost of revenue:
Cost of revenue	54,149	46,735	163,428	136,326
Net administrative fees
Net revenue:
Net revenue	148,441	148,396	452,870	448,261
Software licenses, other services and support
Net revenue:
Net revenue	116,579	105,808	359,795	320,109
Products
Net revenue:
Net revenue	57,212	93,629	183,066	323,825
Cost of revenue:
Cost of revenue	$ 49,013	$ 88,621	$ 168,507	$ 294,916

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Class A Common Stock	Common Stock Class A Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Jun. 30, 2021			122,533,000
Beginning balance at Jun. 30, 2021	$ 2,229,893		$ 1,225	$ 0	$ 2,059,194	$ 169,474	$ 0
Treasury stock, beginning balance (in shares) at Jun. 30, 2021				0
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			1,239,000
Issuance of Class A common stock under equity incentive plan	22,864		$ 13		22,851
Treasury stock (in shares)			(1,091,000)	(1,091,000)
Treasury stock	(42,628)			$ (42,628)
Stock-based compensation expense	7,554				7,554
Repurchase of vested restricted units for employee tax-withholding	(9,171)				(9,171)
Net income	121,306					121,306
Net income attributable to non-controlling interest	0				(698)	698
Dividends	(24,877)					(24,877)
Non-controlling interest related to acquisition	23,145				23,145
Ending balance (in shares) at Sep. 30, 2021			122,681,000
Ending balance at Sep. 30, 2021	2,328,086		$ 1,238	$ (42,628)	2,102,875	266,601	0
Treasury stock, ending balance (in shares) at Sep. 30, 2021				1,091,000
Increase (Decrease) in Stockholders' Equity
Dividends declared (in dollars per share)		$ 0.20
Beginning balance (in shares) at Jun. 30, 2021			122,533,000
Beginning balance at Jun. 30, 2021	2,229,893		$ 1,225	$ 0	2,059,194	169,474	0
Treasury stock, beginning balance (in shares) at Jun. 30, 2021				0
Increase (Decrease) in Stockholders' Equity
Net income	237,607
Ending balance (in shares) at Mar. 31, 2022			117,986,000
Ending balance at Mar. 31, 2022	2,233,602		$ 1,244	$ (250,129)	2,150,313	332,171	3
Treasury stock, ending balance (in shares) at Mar. 31, 2022				6,429,000
Beginning balance (in shares) at Sep. 30, 2021			122,681,000
Beginning balance at Sep. 30, 2021	2,328,086		$ 1,238	$ (42,628)	2,102,875	266,601	0
Treasury stock, beginning balance (in shares) at Sep. 30, 2021				1,091,000
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			579,000
Issuance of Class A common stock under equity incentive plan	14,403		$ 5		14,398
Issuance of Class A common stock under employee stock purchase plan (in shares)			52,000
Issuance of Class A common stock under employee stock purchase plan	1,977		$ 1		1,976
Treasury stock (in shares)			(3,377,000)	(3,377,000)
Treasury stock	(133,396)			$ (133,396)
Stock-based compensation expense	16,234				16,234
Repurchase of vested restricted units for employee tax-withholding	(1,495)				(1,495)
Net income	77,232					77,232
Net income attributable to non-controlling interest	0				1,687	(1,687)
Change in ownership of consolidated entity	12				12
Dividends	(24,250)					(24,250)
Foreign currency translation adjustment	(1)						(1)
Ending balance (in shares) at Dec. 31, 2021			119,935,000
Ending balance at Dec. 31, 2021	2,278,802		$ 1,244	$ (176,024)	2,135,687	317,896	(1)
Treasury stock, ending balance (in shares) at Dec. 31, 2021				4,468,000
Increase (Decrease) in Stockholders' Equity
Dividends declared (in dollars per share)		0.20
Issuance of Class A common stock under equity incentive plan (in shares)			12,000
Issuance of Class A common stock under equity incentive plan	118		$ 0		118
Treasury stock (in shares)			(1,961,000)	(1,961,000)
Treasury stock	(74,105)			$ (74,105)
Stock-based compensation expense	14,004				14,004
Repurchase of vested restricted units for employee tax-withholding	(174)				(174)
Net income	39,069					39,069
Net income attributable to non-controlling interest	0				654	(654)
Change in ownership of consolidated entity	24				24
Dividends	(24,140)					(24,140)
Foreign currency translation adjustment	4						4
Ending balance (in shares) at Mar. 31, 2022			117,986,000
Ending balance at Mar. 31, 2022	2,233,602		$ 1,244	$ (250,129)	2,150,313	332,171	3
Treasury stock, ending balance (in shares) at Mar. 31, 2022				6,429,000
Increase (Decrease) in Stockholders' Equity
Dividends declared (in dollars per share)		$ 0.20
Beginning balance (in shares) at Jun. 30, 2022		118,052,235	118,052,000
Beginning balance at Jun. 30, 2022	$ 2,248,850		$ 1,245	$ (250,129)	2,166,047	331,690	(3)
Treasury stock, beginning balance (in shares) at Jun. 30, 2022	6,429,375			6,429,000
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			694,000
Issuance of Class A common stock under equity incentive plan	$ 644		$ 7		637
Stock-based compensation expense	7,136				7,136
Repurchase of vested restricted units for employee tax-withholding	(13,089)				(13,089)
Net income	42,959					42,959
Net income attributable to non-controlling interest	0				243	(243)
Change in ownership of consolidated entity	26				26
Dividends	(25,097)					(25,097)
Foreign currency translation adjustment	(10)						(10)
Ending balance (in shares) at Sep. 30, 2022			118,746,000
Ending balance at Sep. 30, 2022	2,261,419		$ 1,252	$ (250,129)	2,161,000	349,309	(13)
Treasury stock, ending balance (in shares) at Sep. 30, 2022				6,429,000
Increase (Decrease) in Stockholders' Equity
Dividends declared (in dollars per share)		$ 0.21
Beginning balance (in shares) at Jun. 30, 2022		118,052,235	118,052,000
Beginning balance at Jun. 30, 2022	$ 2,248,850		$ 1,245	$ (250,129)	2,166,047	331,690	(3)
Treasury stock, beginning balance (in shares) at Jun. 30, 2022	6,429,375			6,429,000
Increase (Decrease) in Stockholders' Equity
Net income	$ 155,982
Ending balance (in shares) at Mar. 31, 2023		118,880,307	118,880,000
Ending balance at Mar. 31, 2023	$ 2,335,791		$ 1,253	$ (250,129)	2,175,048	409,630	(11)
Treasury stock, ending balance (in shares) at Mar. 31, 2023	6,429,375			6,429,000
Beginning balance (in shares) at Sep. 30, 2022			118,746,000
Beginning balance at Sep. 30, 2022	$ 2,261,419		$ 1,252	$ (250,129)	2,161,000	349,309	(13)
Treasury stock, beginning balance (in shares) at Sep. 30, 2022				6,429,000
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			54,000
Issuance of Class A common stock under equity incentive plan	60				60
Issuance of Class A common stock under employee stock purchase plan (in shares)			67,000
Issuance of Class A common stock under employee stock purchase plan	2,268		$ 1		2,267
Stock-based compensation expense	2,679				2,679
Repurchase of vested restricted units for employee tax-withholding	(41)				(41)
Net income	64,374					64,374
Net income attributable to non-controlling interest	0				328	(328)
Change in ownership of consolidated entity	26				26
Dividends	(25,303)					(25,303)
Foreign currency translation adjustment	1						1
Other	590				590
Ending balance (in shares) at Dec. 31, 2022			118,867,000
Ending balance at Dec. 31, 2022	2,306,073		$ 1,253	$ (250,129)	2,166,909	388,052	(12)
Treasury stock, ending balance (in shares) at Dec. 31, 2022				6,429,000
Increase (Decrease) in Stockholders' Equity
Dividends declared (in dollars per share)		$ 0.21
Issuance of Class A common stock under equity incentive plan (in shares)			13,000
Issuance of Class A common stock under equity incentive plan	0				0
Stock-based compensation expense	6,560				6,560
Repurchase of vested restricted units for employee tax-withholding	(297)				(297)
Net income	48,649					48,649
Net income attributable to non-controlling interest	0				1,848	(1,848)
Change in ownership of consolidated entity	28				28
Dividends	(25,223)					(25,223)
Foreign currency translation adjustment	1						1
Ending balance (in shares) at Mar. 31, 2023		118,880,307	118,880,000
Ending balance at Mar. 31, 2023	$ 2,335,791		$ 1,253	$ (250,129)	$ 2,175,048	$ 409,630	$ (11)
Treasury stock, ending balance (in shares) at Mar. 31, 2023	6,429,375			6,429,000
Increase (Decrease) in Stockholders' Equity
Dividends declared (in dollars per share)		$ 0.21

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021
Class A Common Stock
Dividends declared (in dollars per share)	$ 0.21	$ 0.21	$ 0.21	$ 0.20	$ 0.20	$ 0.20

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities
Net income	$ 155,982	$ 237,607
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	100,568	95,764
Equity in net income of unconsolidated affiliates	(14,547)	(17,165)
Deferred income taxes	2,083	36,926
Stock-based compensation	16,375	37,792
Gain on FFF Put and Call Rights	0	(64,110)
Other, net	3,066	4,578
Changes in operating assets and liabilities, net of the effects of acquisitions:
Accounts receivable, inventories, prepaid expenses and other assets	47,389	91,418
Contract assets	(31,975)	(39,139)
Accounts payable, accrued expenses, deferred revenue, revenue share obligations and other liabilities	52,237	(48,882)
Net cash provided by operating activities	331,178	334,789
Investing activities
Purchases of property and equipment	(58,464)	(61,061)
Acquisition of businesses and equity method investments, net of cash acquired	(187,750)	(26,000)
Investment in unconsolidated affiliates	(2,060)	(16,000)
Other	(1,510)	(10,000)
Net cash used in investing activities	(249,784)	(113,061)
Financing activities
Payments made on notes payable	(76,024)	(75,082)
Proceeds from credit facility	350,000	300,000
Payments on credit facility	(265,000)	(125,000)
Proceeds from exercise of stock options under equity incentive plan	704	37,385
Cash dividends paid	(75,227)	(72,861)
Repurchase of Class A common stock (held as treasury stock)	0	(250,129)
Other, net	(10,489)	14,318
Net cash used in financing activities	(76,036)	(171,369)
Effect of exchange rate changes on cash flows	(8)	3
Net increase in cash and cash equivalents	5,350	50,362
Cash and cash equivalents at beginning of period	86,143	129,141
Cash and cash equivalents at end of period	$ 91,493	$ 179,503

ORGANIZATION

ORGANIZATION	9 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	(1) ORGANIZATION Organization Premier, Inc. (“Premier” or the “Company”) is a publicly held, for-profit Delaware corporation located in the United States. The Company is a holding company with no material business operations of its own. The Company’s primary asset is its equity interest in its wholly owned subsidiary Premier Healthcare Solutions, Inc., a Delaware corporation (“PHSI”). The Company conducts substantially all of its business operations through PHSI and its other consolidated subsidiaries. The Company, together with its subsidiaries and affiliates, is a leading healthcare performance improvement company that unites hospitals, health systems, physicians, employers, product suppliers, service providers, and other healthcare providers and organizations to improve and innovate in the clinical, financial and operational areas of their businesses to meet the demands of a rapidly evolving healthcare industry and continues to expand its capabilities to more fully address and coordinate care improvement and standardization in the employer, payor and life sciences markets. The Company also provides services to other businesses, including food service, schools and universities. The Company’s business model and solutions are designed to provide its members and other customers access to scale efficiencies, spread the cost of their development, provide actionable intelligence derived from anonymized data in the Company’s enterprise data warehouse, mitigate the risk of innovation and disseminate best practices to help the Company’s members and other customers succeed in their transformation to higher quality and more cost-effective healthcare. The Company, together with its subsidiaries and affiliates, delivers its integrated platform of solutions through two business segments: Supply Chain Services and Performance Services. See Note 14 - Segments for further information related to the Company’s reportable business segments. The Supply Chain Services segment includes one of the largest healthcare group purchasing organization (“GPO”) programs in the United States, supply chain co-management, purchased services and direct sourcing activities. The Performance Services segment consists of three sub-brands: PINC AI TM , the Company’s technology and services platform with offerings that help optimize performance in three main areas – clinical intelligence, margin improvement and value-based care – using advanced analytics to identify improvement opportunities, consulting and managed services for clinical and operational design, and workflow solutions to hardwire sustainable change in the provider, life sciences and payer markets; Contigo Health ® , the Company’s direct-to-employer business which provides third-party administrator services and management of health-benefit programs that allow employers to contract directly with healthcare providers as well as partner with healthcare providers to provide employers access to a specialized care network through Contigo Health’s centers of excellence program and cost containment and wrap network; and Remitra TM , the Company’s digital invoicing and payables automation business which provides financial support services to healthcare providers and suppliers. Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which the Company exercised control and when applicable, entities for which the Company had a controlling financial interest or was the primary beneficiary. All intercompany transactions have been eliminated upon consolidation. Accordingly, certain information and disclosures normally included in annual financial statements have been condensed or omitted. The accompanying condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of results of operations and financial condition for the interim periods shown, consisting of normal recurring adjustments, unless otherwise disclosed. The Company believes that the disclosures are adequate to make the information presented not misleading and should be read in conjunction with the audited consolidated financial statements and related footnotes contained in the 2022 Annual Report. Supplementary Cash Flows Information The following table presents supplementary cash flows information for the nine months ended March 31, 2023 and 2022 (in thousands): Nine Months Ended March 31, 2023 2022 Supplemental schedule of non-cash investing and financing activities: Non-cash additions to property and equipment $ 5 $ 129 Non-cash investment in unconsolidated affiliates 7,800 — Accrued dividend equivalents 778 738 Use of Estimates in the Preparation of Financial Statements The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. Significant estimates are evaluated on an ongoing basis, including, but not limited to, estimates for net administrative fees revenue, software licenses, other services and support revenue, contract assets, deferred revenue, contract costs, allowances for credit losses, reserves for net realizable value of inventory, obsolete inventory, useful lives of property and equipment, stock-based compensation, deferred tax balances including valuation allowances on deferred tax assets, uncertain tax positions, values of investments not publicly traded, projected future cash flows used in the evaluation of asset impairments, values of call rights, values of earn-out liabilities and the allocation of purchase prices. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	(2) SIGNIFICANT ACCOUNTING POLICIES There have been no material changes to the Company’s significant accounting policies as described in the 2022 Annual Report. Recently Adopted Accounting Standards In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, (“ASU 2021-08”), which requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 during the second quarter of fiscal 2023. The standard did not have a material impact on the Company’s financial statements nor its related disclosures.

BUSINESS ACQUISITIONS

BUSINESS ACQUISITIONS	9 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
BUSINESS ACQUISITIONS	(3) BUSINESS ACQUISITIONS Acquisition of TRPN Direct Pay, Inc. and Devon Health, Inc. Assets On October 13, 2022, the Company, through its consolidated subsidiary Contigo Health, LLC (“Contigo Health”), acquired certain assets (the “TRPN Transferred Assets”) of TRPN Direct Pay, Inc. and Devon Health, Inc. (collectively, “TRPN”), including contracts with more than 900,000 providers (collectively, the “Assumed Contracts”), and agreed to assume certain liabilities and obligations of TRPN with regard to the Assumed Contracts (referred to as the “TRPN acquisition”). The TRPN Transferred Assets relate to businesses of TRPN focused on improving access to quality healthcare and reducing the cost of medical claims through pre-negotiated discounts with network providers, including acute-care hospitals, surgery centers, physicians and other non-acute providers in the United States. Contigo Health also agreed to license proprietary cost containment technology of TRPN. The purchase price paid by the Company to complete the TRPN acquisition consisted of cash of $177.5 million, funded with borrowings under the Company’s Credit Facility (as defined in Note 8 - Debt and Notes Payable) and cash on hand, of which $17.8 million was placed in escrow to satisfy indemnification obligations of TRPN to Contigo Health and its affiliates and other parties related thereto under the purchase agreement governing the TRPN acquisition. The Company has accounted for the TRPN acquisition as a business combination whereby the purchase price was allocated to tangible and intangible assets acquired and liabilities assumed based on their fair values. The total fair value assigned to intangible assets acquired was $116.6 million, consisting primarily of the provider network. The TRPN acquisition resulted in the recognition of $60.9 million of goodwill attributable to the anticipated profitability of TRPN, based on the purchase price paid in the acquisition compared to the fair value of the net assets acquired. The TRPN acquisition was considered an asset acquisition for income tax purposes. Accordingly, the Company expects tax goodwill to be deductible for tax purposes. The initial purchase price allocation for the TRPN acquisition is preliminary and subject to changes in the valuation of the assets acquired and liabilities assumed. TRPN is being integrated within Premier under Contigo Health and is reported as part of the Performance Services Segment. Pro forma results of operations for the acquisition have not been presented because the effects on revenue and net income were not material to the Company’s historical consolidated financial statements.

INVESTMENTS

INVESTMENTS	9 Months Ended
	Mar. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS	(4) INVESTMENTS Investments in Unconsolidated Affiliates The Company’s investments in unconsolidated affiliates consisted of the following (in thousands): Equity in Net Income Three Months Ended Nine Months Ended Carrying Value March 31, March 31, March 31, 2023 June 30, 2022 2023 2022 2023 2022 FFF $ 136,584 $ 137,162 $ 1,370 $ 2,437 $ 9,075 $ 11,836 Exela 31,368 27,733 2,865 501 3,635 1,504 Qventus 16,000 16,000 — — — — Prestige 16,206 15,597 139 935 610 3,272 Other investments 30,142 19,053 256 118 1,227 553 Total investments $ 230,300 $ 215,545 $ 4,630 $ 3,991 $ 14,547 $ 17,165 The Company, through its indirect, wholly owned subsidiary Premier Supply Chain Improvement, Inc. (“PSCI”), held a 49% interest in FFF Enterprises, Inc. (“FFF”) through its ownership of stock of FFF at March 31, 2023 and June 30, 2022. The Company accounts for its investment in FFF as part of the Supply Chain Services segment. On March 3, 2023, the Company and the majority shareholder of FFF amended the FFF shareholders’ agreement and in lieu of a distribution, the Company received an increase of $24.8 million to the its liquidation preferences on the Class B common stock in FFF, bringing the Company’s total liquidation preference in FFF to $32.3 million. In the event of liquidation or dissolution of FFF, the Company will receive the liquidation preference of $32.3 million prior to any pro rata distribution of FFF’s proportional equity value between the Company and the majority shareholder of FFF. As a result of the increase to the liquidation preference and priority of the Company’s Class B common stock in FFF in the event of liquidation or dissolution of FFF, the Company will no longer account for its investment in FFF using the equity method of accounting. As of the date of the amendment, the Company will account for its investment in FFF at cost less impairments, if any, plus or minus any observable changes in fair value. The Company, through its consolidated subsidiary, ExPre Holdings, LLC (“ExPre”), held an approximate 6% interest in Exela Holdings, Inc. (“Exela”) through its ownership of Exela Class A common stock at March 31, 2023. At March 31, 2023, the Company owned approximately 15% of the membership interest of ExPre, with the remainder of the membership interests held by 11 member health systems or their affiliates. The Company, through its consolidated subsidiary, PRAM Holdings, LLC (“PRAM”), held an approximate 20% interest in Prestige Ameritech Ltd. (“Prestige”) through its ownership of Prestige limited partnership units at March 31, 2023. At March 31, 2023, the Company owned approximately 26% of the membership interest of PRAM, with the remainder of the membership interests held by 16 member health systems or their affiliates. The Company accounts for its investments in Exela and Prestige using the equity method of accounting and includes each investment as part of the Supply Chain Services segment. The Company, through PHSI, purchased an approximate 7% interest in Qventus, Inc. (“Qventus”) through its ownership of Qventus Series C preferred stock. The Company accounts for its investment in Qventus at cost less impairments, if any, plus or minus any observable changes in fair value. The Company includes Qventus as part of the Performance Services segment.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	(5) FAIR VALUE MEASUREMENTS Recurring Fair Value Measurements The following table represents the Company’s financial assets and liabilities, which are measured at fair value on a recurring basis (in thousands): Fair Value of Financial Assets and Liabilities Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs March 31, 2023 Cash equivalents $ 76 $ 76 $ — $ — Deferred compensation plan assets 52,787 52,787 — — Total assets 52,863 52,863 — — Earn-out liabilities 27,174 — — 27,174 Total liabilities $ 27,174 $ — $ — $ 27,174 June 30, 2022 Cash equivalents $ 75 $ 75 $ — $ — Deferred compensation plan assets 52,718 52,718 — — Total assets 52,793 52,793 — — Earn-out liabilities 22,789 — — 22,789 Total liabilities $ 22,789 $ — $ — $ 22,789 Deferred compensation plan assets consisted of highly liquid mutual fund investments, which were classified as Level 1. The current portion of deferred compensation plan assets ($5.1 million and $5.3 million at March 31, 2023 and June 30, 2022, respectively) was included in prepaid expenses and other current assets in the accompanying Condensed Consolidated Balance Sheets. Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) FFF Put and Call Rights On July 29, 2021, the FFF shareholders’ agreement was amended resulting in the termination of the FFF Put Right and the derecognition of the FFF Put Right liability. In the event of a Key Man Event (generally defined in the FFF shareholders’ agreement as the resignation, termination for cause, death or disability of the majority shareholder), the Company has a call right that requires the majority shareholder to sell its remaining interest in FFF to the Company, and is exercisable at any time within 180 calendar days after the date of a Key Man Event (the “Call Right”, together with the FFF Put Right, the “Put and Call Rights”). As of March 31, 2023 and June 30, 2022, the Call Right had zero value. In the event that the Call Right is exercised, the purchase price for the additional interest in FFF will be at a per share price equal to FFF’s earnings before interest, taxes, depreciation and amortization (“FFF EBITDA”) over the twelve calendar months prior to the purchase date multiplied by a market adjusted multiple, adjusted for any outstanding debt and cash and cash equivalents, divided by the number of shares of FFF common stock then outstanding (“Equity Value per Share”). Earn-out liabilities At March 31, 2023, earn-out liabilities have been established in connection with certain of our acquisitions, including the acquisition of substantially all of the assets and certain liabilities of Acurity, Inc. and Nexera, Inc. (the “Acurity and Nexera asset acquisition”) in February 2020 as well as other immaterial acquisitions. The earnout liability related to the Acurity and Nexera asset acquisition was based upon the Company’s achievement of a range of member renewals on terms to be agreed to by the Company and Greater New York Hospital Association based on prevailing market conditions in December 2023. Earn-out liabilities are classified as Level 3 of the fair value hierarchy. Acurity and Nexera Earn-out (a) The earn-out liability arising from expected earn-out payments related to the Acurity and Nexera asset acquisition was measured on the acquisition date using a probability-weighted expected payment model and is remeasured periodically due to changes in management’s estimates of the number of transferred member renewals and market conditions. In determining the fair value of the contingent liabilities, management reviews the current results of the acquired business, along with projected results for the remaining earn-out period, to calculate the expected earn-out payment to be made based on the contractual terms set out in the acquisition agreement. The Acurity and Nexera earn-out liability utilized a credit spread of 1.8% at March 31, 2023 and 1.6% at June 30, 2022. As of March 31, 2023 and June 30, 2022, the undiscounted range of outcomes is between $0 and $30.0 million. A significant decrease in the probability could result in a significant decrease in the value of the earn-out liability. The fair value of the Acurity and Nexera earn-out liability at March 31, 2023 and June 30, 2022 was $23.0 million and $22.8 million, respectively. Input assumptions As of March 31, 2023 As of June 30, 2022 Probability of transferred member renewal percentage < 50% 5.0 % 5.0 % Probability of transferred member renewal percentage between 50% and 65% 10.0 % 10.0 % Probability of transferred member renewal percentage between 65% and 80% 25.0 % 25.0 % Probability of transferred member renewal percentage > 80% 60.0 % 60.0 % Credit spread 1.8 % 1.6 % _________________________________ (a) The Acurity and Nexera earn-out liability was initially valued as of February 28, 2020. A reconciliation of the Company’s earn-out liabilities and FFF Put Right is as follows (in thousands): Beginning Balance Purchases (Settlements) (a) (Gain)/Loss (b) Ending Balance Three Months Ended March 31, 2023 Earn-out liabilities $ 24,098 $ — $ 3,076 $ 27,174 Total Level 3 liabilities $ 24,098 $ — $ 3,076 $ 27,174 Three Months Ended March 31, 2022 Earn-out liabilities $ 24,139 $ — $ (945) $ 23,194 Total Level 3 liabilities $ 24,139 $ — $ (945) $ 23,194 Nine Months Ended March 31, 2023 Earn-out liabilities $ 22,789 $ 1,460 $ 2,925 $ 27,174 Total Level 3 liabilities $ 22,789 $ 1,460 $ 2,925 $ 27,174 Nine Months Ended March 31, 2022 Earn-out liabilities $ 24,249 $ — $ (1,055) $ 23,194 FFF put right 64,110 (64,110) — — Total Level 3 liabilities $ 88,359 $ (64,110) $ (1,055) $ 23,194 _________________________________ (a) Purchases for the nine months ended March 31, 2023 includes an earn-out which has not been earned or paid as of March 31, 2023. Settlements for the nine months ended March 31, 2022 includes non-cash gain recognized as a result the termination of the FFF Put Right and the derecognition of the FFF Put Right liability. (b) A gain on level 3 liability balances will decrease the liability ending balance whereas a loss on level 3 liability balance will increase the liability ending balance. Non-Recurring Fair Value Measurements As a result of the August 2020 Restructuring, the Company recorded non-interest bearing notes payable to former limited partners during the three months ended September 30, 2020. Although these notes are non-interest bearing, they include a Level 2 input associated with an implied fixed annual interest rate of 1.8% (see Note 8 - Debt and Notes Payable). As of March 31, 2023 and June 30, 2022, the notes payable to former limited partners were recorded net of discounts of $5.2 million and $9.1 million, respectively. During the nine months ended March 31, 2023, no non-recurring fair value measurements were required relating to the measurement of goodwill and intangible assets for impairment. However, purchase price allocations required significant non-recurring Level 3 inputs. The preliminary fair values of the acquired intangible assets resulting from the TRPN acquisition were determined using the income approach (see Note 3 - Business Acquisitions). Financial Instruments For Which Fair Value Only is Disclosed The fair values of non-interest bearing notes payable, classified as Level 2, were equal to the carrying value at March 31, 2023 and $0.1 million less than the carrying value at June 30, 2022 based on an assumed market interest rate of 1.6%. Other Financial Instruments The fair values of cash, accounts receivable, accounts payable, accrued liabilities and the Credit Facility (as defined in Note 8 - Debt and Notes Payable) approximated carrying value due to the short-term nature of these financial instruments.

CONTRACT BALANCES

CONTRACT BALANCES	9 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
CONTRACT BALANCES	(6) CONTRACT BALANCES Deferred Revenue Revenue recognized during the nine months ended March 31, 2023 that was included in the opening balance of deferred revenue at June 30, 2022 was $25.5 million, which is a result of satisfying certain performance obligations. Performance Obligations A performance obligation is a contractual obligation to transfer a distinct good or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Contracts may have a single performance obligation as the agreement to transfer individual goods or services is not separately identifiable from other contractual obligations and, therefore, not distinct, while other contracts may have multiple performance obligations, most commonly due to the contract covering multiple phases or deliverable arrangements (licensing fees, SaaS subscription fees, maintenance and support fees, and professional fees for consulting services). Refer to the Company’s significant accounting policies in the 2022 Annual Report for discussion of revenue recognition on contracts with customers. Net revenue of $5.4 million and $3.9 million was recognized during the three and nine months ended March 31, 2023, respectively, from certain performance obligations that were satisfied or partially satisfied in prior periods. The net revenue recognized was driven by an increase of $6.1 million and $6.6 million, respectively, in net administrative fees revenue related to under-forecasted cash receipts received in the current period. These increases were partially offset by a reduction of $0.7 million and $2.7 million, respectively, associated with revised forecasts from underlying contracts that include variable consideration components as well as additional fluctuations due to input method contracts which occur in the normal course of business. Net revenue of $5.7 million and $3.6 million was recognized during the three and nine months ended March 31, 2022, respectively, from certain performance obligations that were satisfied or partially satisfied in prior periods. The net revenue recognized was driven by an increase of $5.4 million and $3.3 million, respectively, in net administrative fees revenue related to under-forecasted cash receipts received in the current period. In addition, net revenue recognized in both periods was driven by an increase of $0.3 million associated with revised forecasts from underlying contracts that include variable consideration components as well as additional fluctuations due to input method contracts which occur in the normal course of business. Remaining performance obligations represent the portion of the transaction price that has not yet been satisfied or achieved. As of March 31, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $701.7 million. The Company expects to recognize approximately 40% of the remaining performance obligations over the next 12 months and an additional 23% over the following 12 months, with the remainder recognized thereafter.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	9 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	(7) GOODWILL AND INTANGIBLE ASSETS Goodwill Goodwill consisted of the following (in thousands): Supply Chain Services Performance Services Total June 30, 2022 $ 388,502 $ 611,411 $ 999,913 Acquisition of businesses and assets — 69,160 69,160 March 31, 2023 $ 388,502 $ 680,571 $ 1,069,073 Goodwill increased primarily due to the TRPN acquisition (see Note 3 - Business Acquisitions). The initial purchase price allocation for the TRPN acquisition is preliminary and subject to change in the valuation of the assets acquired and the liabilities assumed. Intangible Assets, Net Intangible assets, net consisted of the following (in thousands): Useful Life March 31, 2023 June 30, 2022 Member relationships 14.7 years $ 386,100 $ 386,100 Provider network 15.0 years 106,500 — Technology 7.1 years 99,317 98,017 Customer relationships 9.4 years 57,930 47,830 Non-compete agreements 5.2 years 17,715 17,315 Trade names 6.7 years 18,920 17,210 Other (a) 9.3 years 9,233 7,682 Total intangible assets 695,715 574,154 Accumulated amortization (252,997) (217,582) Total intangible assets, net $ 442,718 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. The net carrying value of intangible assets by segment was as follows (in thousands): March 31, 2023 June 30, 2022 Supply Chain Services $ 277,641 $ 301,611 Performance Services (a) 165,077 54,961 Total intangible assets, net $ 442,718 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. Total intangible assets increased primarily due to the TRPN acquisition (see Note 3 - Business Acquisitions). As part of the TRPN acquisition, the total fair value assigned to intangible assets acquired was $116.6 million, consisting primarily of the provider network of $106.5 million. The weighted average useful life of the acquired intangible assets is 14.1 years, with the provider network having a useful life of 15.0 years. Intangible asset amortization was $11.9 million and $11.2 million for the three months ended March 31, 2023 and 2022, respectively, and $35.4 million and $32.9 million for the nine months ended March 31, 2023 and 2022, respectively. The estimated amortization expense for each of the next five fiscal years and thereafter is as follows (in thousands): 2023 (a) $ 12,688 2024 49,761 2025 48,136 2026 46,892 2027 44,240 Thereafter 240,001 Total amortization expense $ 441,718 (a) As of March 31, 2023, estimated amortization expense is for the period from April 1, 2023 to June 30, 2023.

DEBT AND NOTES PAYABLE

DEBT AND NOTES PAYABLE	9 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
DEBT AND NOTES PAYABLE	(8) DEBT AND NOTES PAYABLE Long-term debt and notes payable consisted of the following (in thousands): March 31, 2023 June 30, 2022 Credit facility $ 235,000 $ 150,000 Notes payable to members, net of discount 225,814 298,994 Other notes payable 2,280 5,333 Total debt and notes payable 463,094 454,327 Less: current portion (335,472) (250,859) Total long-term debt and notes payable $ 127,622 $ 203,468 Credit Facility PHSI, along with its consolidated subsidiaries, Premier LP and PSCI (“Co-Borrowers”), and certain domestic subsidiaries of the Co-Borrowers, as guarantors, entered into an unsecured Amended and Restated Credit Agreement, dated as of December 12, 2022 (the “Credit Facility”). The Credit Facility has a maturity date of December 12, 2027, subject to up to two one-year extensions at the request of the Co-Borrowers and approval of a majority of the lenders under the Credit Facility. The Credit Facility provides for borrowings of up to $1.0 billion with (i) a $50.0 million sub-facility for standby letters of credit and (ii) a $100.0 million sub-facility for swingline loans. The Credit Facility also provides that Co-Borrowers may from time to time (i) incur incremental term loans and (ii) request an increase in the revolving commitments under the Credit Facility, together up to an aggregate of $350.0 million, subject to the approval of the lenders providing such term loans or revolving commitment increase. The Credit Facility contains an unconditional and irrevocable guaranty of all obligations of Co-Borrowers under the Credit Facility by the current and future guarantors. Premier is not a guarantor under the Credit Facility. The Credit Facility refinanced the Credit Agreement, dated as of November 9, 2018, as amended (the “Prior Loan Agreement”), and the Prior Loan Agreement, which was scheduled to mature on November 9, 2023, was terminated on December 12, 2022. The Prior Loan Agreement included a $1.0 billion unsecured revolving credit facility. At the time of its termination, outstanding borrowings, accrued interest and fees and expenses under the Prior Loan Agreement totaled $331.3 million, which was repaid with cash on hand and borrowings under the Credit Facility. At the Company’s option, committed loans under the Credit Facility may be in the form of secured overnight financing rate loans (“SOFR Loans”) or base rate loans. SOFR Loans bear interest at Term SOFR plus an adjustment of 0.100% (“Adjusted Term SOFR”) plus the Applicable Rate (defined as a margin based on the Consolidated Total Net Leverage Ratio (as defined in the Credit Facility)). Base rate loans bear interest at the Base Rate (defined as the highest of the prime rate announced by the administrative agent, the federal funds effective rate plus 0.500%, the one-month Adjusted Term SOFR plus 1.000%, and 0.000%), plus the Applicable Rate. The Applicable Rate ranges from 1.250% to 1.750% for SOFR Loans and 0.250% to 0.750% for base rate loans. At March 31, 2023, the interest rates for SOFR Loans and base rate loans were 6.152% and 8.250%, respectively. Co-Borrowers are required to pay a commitment fee ranging from 0.125% to 0.225% per annum on the actual daily unused amount of commitments under the Credit Facility. At March 31, 2023, the weighted average interest rate on outstanding borrowings under the Credit Facility was 6.195% and the annual commitment fee, based on the actual daily unused amount of commitments under the Credit Facility, was 0.125%. The Credit Facility contains customary representations and warranties as well as customary affirmative and negative covenants, including, among others, limitations on liens, indebtedness, fundamental changes, dispositions, restricted payments and investments. The Company was in compliance with all such covenants at March 31, 2023. The Credit Facility also contains customary events of default, including a cross-default of any indebtedness or guarantees in excess of $75.0 million. If any event of default occurs and is continuing, the administrative agent under the Credit Facility may, with the consent, or shall, at the request of a majority of the lenders under the Credit Facility, terminate the commitments and declare all of the amounts owed under the Credit Facility to be immediately due and payable. The Company had $235.0 million in outstanding borrowings under the Credit Facility at March 31, 2023 with $765.0 million of available borrowing capacity after reductions for outstanding borrowings and outstanding letters of credit. For the nine months ended March 31, 2023, the Company borrowed $285.0 million and repaid $135.0 million of outstanding borrowings under the Prior Loan Agreement. For the nine months ended March 31, 2023, the Company borrowed $65.0 million and repaid $130.0 million of outstanding borrowings under the Credit Facility. In April 2023, the Company repaid $60.0 million of outstanding borrowings under the Credit Facility. Notes Payable Notes Payable to Former Limited Partners At March 31, 2023, the Company had $225.8 million of notes payable to former LPs, net of discounts on notes payable of $5.2 million, of which $99.2 million was recorded to current portion of notes payable to former limited partners in the accompanying Condensed Consolidated Balance Sheets. At June 30, 2022, the Company had $299.0 million of notes payable to former LPs, net of discounts on notes payable of $9.1 million, of which $97.8 million was recorded to current portion of notes payable to former limited partners in the accompanying Condensed Consolidated Balance Sheets. The notes payable to former LPs were issued in connection with the early termination of the TRA as part of the August 2020 Restructuring. Although the notes payable to former LPs are non-interest bearing, pursuant to GAAP requirements, they were recorded net of imputed interest at a fixed annual rate of 1.8%. Other At March 31, 2023 and June 30, 2022, the Company had $2.3 million and $5.3 million in other notes payable, respectively, of which $1.3 million and $3.1 million, respectively, were included in current portion of long-term debt in the accompanying Condensed Consolidated Balance Sheets. Other notes payable do not bear interest and generally have stated maturities of three

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Mar. 31, 2023
Equity [Abstract]
STOCKHOLDERS' EQUITY	(9) STOCKHOLDERS' EQUITY As of March 31, 2023, there were 118,880,307 shares of the Company’s Class A common stock, par value $0.01 per share, outstanding. During the nine months ended March 31, 2023, the Company paid cash dividends of $0.21 per share on outstanding shares of Class A common stock to stockholders on each of September 15, 2022, December 15, 2022 and March 15, 2023. On April 27, 2023, the Board of Directors declared a quarterly cash dividend of $0.21 per share, payable on June 15, 2023 to stockholders of record on June 1, 2023.

EARNINGS PER SHARE

EARNINGS PER SHARE	9 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
EARNINGS PER SHARE	(10) EARNINGS PER SHARE Basic earnings per share is computed by dividing net income attributable to stockholders by the weighted average number of shares of common stock outstanding for the period. Except when the effect would be anti-dilutive, the diluted earnings per share calculation, which is calculated using the treasury stock method, includes the impact of all potentially issuable dilutive shares of Class A common stock. The following table provides a reconciliation of the numerator and denominator used for basic and diluted earnings per share (in thousands, except per share amounts): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Numerator for basic earnings per share: Net income attributable to stockholders (a) $ 46,801 $ 38,415 $ 153,563 $ 235,964 Numerator for diluted earnings per share: Net income attributable to stockholders (a) $ 46,801 $ 38,415 $ 153,563 $ 235,964 Net loss attributable to non-controlling interest — — — 1,643 Net income for diluted earnings per share $ 46,801 $ 38,415 $ 153,563 $ 237,607 Denominator for earnings per share: Basic weighted average shares outstanding (b) 118,872 118,697 118,668 120,957 Effect of dilutive securities: (c) Stock options 76 98 103 225 Restricted stock 528 465 519 499 Performance share awards 340 553 542 621 Diluted weighted average shares and assumed conversions 119,816 119,813 119,832 122,302 Earnings per share attributable to stockholders: Basic $ 0.39 $ 0.32 $ 1.29 $ 1.95 Diluted $ 0.39 $ 0.32 $ 1.28 $ 1.94 _________________________________ (a) Net income attributable to stockholders was calculated as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Net income $ 48,649 $ 39,069 $ 155,982 $ 237,607 Net income attributable to non-controlling interest (1,848) (654) (2,419) (1,643) Net income attributable to stockholders $ 46,801 $ 38,415 $ 153,563 $ 235,964 (b) Weighted average number of common shares used for basic earnings per share excludes the impact of all potentially issuable dilutive shares of Class A common stock for the three and nine months ended March 31, 2023 and 2022. (c) The effect of 0.3 million stock options and restricted stock units were excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect for both the three and nine months ended March 31, 2023. Additionally, for the three and nine months ended March 31, 2023, the effect of 0.4 million and 0.3 million performance share awards, respectively, was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period. For the three and nine months ended March 31, 2022, the effect of 0.3 million and 0.6 million stock options and restricted stock units, respectively, was excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect. Additionally, for the nine months ended March 31, 2022, the effect of 0.3 million performance share awards was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	(11) STOCK-BASED COMPENSATION Stock-based compensation expense is recognized over the requisite service period, which generally equals the stated vesting period. The associated deferred tax benefit was calculated at a tax rate of 26% for the nine months ended March 31, 2023 and 2022, which represents the expected effective income tax rate at the time of the compensation expense deduction and differs from the Company’s current effective income tax rate. See Note 12 - Income Taxes for further information. Stock-based compensation expense and the resulting deferred tax benefits were as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Pre-tax stock-based compensation expense $ 6,560 $ 14,004 $ 16,375 $ 37,792 Less: deferred tax benefit (a) 2,400 3,288 4,407 8,013 Total stock-based compensation expense, net of tax $ 4,160 $ 10,716 $ 11,968 $ 29,779 _________________________________ (a) For the three and nine months ended March 31, 2023, the deferred tax benefit was reduced by $0.7 million and $0.2 million, respectively, attributable to stock-based compensation expense that is nondeductible for tax purposes pursuant to Section 162(m) as amended by the Tax Cuts and Jobs Act of 2017. Premier 2013 Equity Incentive Plan The Premier 2013 Equity Incentive Plan, as amended and restated (and including any further amendments thereto, the “2013 Equity Incentive Plan”) provides for grants of up to 14.8 million shares of Class A common stock, all of which are eligible to be issued as non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units or performance share awards. As of March 31, 2023, there were 3.9 million shares available for grant under the 2013 Equity Incentive Plan. The following table includes information related to restricted stock, performance share awards and stock options for the nine months ended March 31, 2023: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 419,519 36.69 823,009 35.34 — — Vested/exercised (257,571) 36.37 (826,743) 36.35 (24,351) 32.84 Forfeited (72,268) 35.81 (81,350) 33.41 (2,906) 35.65 Outstanding at March 31, 2023 1,290,810 $ 35.78 1,493,711 $ 33.09 869,097 $ 30.30 Stock options outstanding and exercisable at March 31, 2023 869,097 $ 30.30 Restricted stock units and restricted stock awards issued and outstanding generally vest over a three-year period for employees and a one-year period for directors. Performance share awards issued and outstanding generally vest over a three-year period if performance targets are met. Stock options generally vest in equal annual installments over three years. Stock options have a term of ten years from the date of grant. Vested stock options will generally expire either twelve months after an employee’s termination with the Company or 90 days after an employee’s termination with the Company, depending on the termination circumstances. Unrecognized stock-based compensation expense at March 31, 2023 was as follows (in thousands): Unrecognized Stock-Based Compensation Expense Weighted Average Amortization Period Restricted stock $ 23,381 1.8 years Performance share awards 22,830 1.8 years Total unrecognized stock-based compensation expense $ 46,211 1.8 years At March 31, 2023, there was no unrecognized stock-based compensation expense for outstanding stock options. The aggregate intrinsic value of stock options at March 31, 2023 was as follows (in thousands): Intrinsic Value of Stock Options Outstanding and exercisable $ 2,325 Exercised during the nine months ended March 31, 2023 78

INCOME TAXES

INCOME TAXES	9 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	(12) INCOME TAXES Income tax expense for the three months ended March 31, 2023 and 2022 was $17.2 million and $14.7 million, respectively, which reflects effective tax rates of 26% and 27%, respectively. The change in the effective tax rate for the three months ended March 31, 2023 is primarily related to changes in stock-based compensation expense. Income tax expense for the nine months ended March 31, 2023 and 2022 was $59.8 million and $40.1 million, respectively, which reflects effective tax rates of 28% and 14%, respectively. The change in the effective tax rate for the nine months ended March 31, 2023, is primarily driven by the prior year valuation allowance release resulting from the Subsidiary Reorganization. Excluding the valuation allowance release, the effective tax rate would have been 25% for the nine months ended March 31, 2022 with the remaining difference primarily related to repricing due to the Subsidiary Reorganization and state legislative changes. As of March 31, 2023, total tax liabilities included $52.3 million within other current liabilities in the accompanying Condensed Consolidated Balance Sheets.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	(13) COMMITMENTS AND CONTINGENCIES Operating Leases Operating lease expense for both the three months ended March 31, 2023 and 2022 was $2.5 million. Operating lease expense for the nine months ended March 31, 2023 and 2022 was $7.5 million and $7.6 million, respectively. As of March 31, 2023, the weighted average remaining lease term was 3.1 years, and the weighted average discount rate was 4%. Future minimum lease payments under noncancellable operating leases with initial lease terms in excess of one year were as follows (in thousands): March 31, 2023 June 30, 2022 2023 (a) $ 2,406 $ 12,131 2024 12,381 12,267 2025 12,389 12,301 2026 9,005 9,005 2027 1,324 1,323 Total future minimum lease payments 37,505 47,027 Less: imputed interest 2,281 3,445 Total operating lease liabilities (b) $ 35,224 $ 43,582 _________________________________ (a) As of March 31, 2023, future minimum lease payments are for the period from April 1, 2023 to June 30, 2023. (b) As of March 31, 2023, total operating lease liabilities included $9.8 million within other current liabilities in the Condensed Consolidated Balance Sheets. Other Matters The Company is not currently involved in any litigation it believes to be material. The Company is periodically involved in litigation, arising in the ordinary course of business or otherwise, which from time to time may include stockholder derivative or other similar litigation, claims relating to commercial, product liability, tort and personal injury, employment, antitrust, intellectual property, or other regulatory matters. If current or future government regulations, including but not limited to those with respect to antitrust or healthcare laws, are interpreted or enforced in a manner adverse to the Company or its business, the Company may be subject to regulatory inquiries or investigations, enforcement actions, penalties and other material limitations which could have a material adverse effect on the Company’s business, financial condition and results of operations.

SEGMENTS

SEGMENTS	9 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
SEGMENTS	(14) SEGMENTS The Company delivers its solutions and manages its business through two reportable business segments, the Supply Chain Services segment and the Performance Services segment. The Supply Chain Services segment includes the Company’s GPO, supply chain co-management, purchased services and direct sourcing activities. The Performance Services segment consists of three sub-brands: PINC AI , the Company’s technology and services platform; Contigo Health , the Company’s direct-to-employer business; and Remitra , the Company’s digital invoicing and payables automation business. The following table presents disaggregated revenue by business segment and underlying source (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Net revenue: Supply Chain Services Net administrative fees $ 148,441 $ 148,396 $ 452,870 $ 448,261 Software licenses, other services and support 11,032 8,914 35,963 27,165 Services and software licenses 159,473 157,310 488,833 475,426 Products 57,212 93,629 183,066 323,825 Total Supply Chain Services (a) 216,685 250,939 671,899 799,251 Performance Services Software licenses, other services and support SaaS-based products subscriptions 44,685 49,347 142,097 144,357 Consulting services 22,087 16,342 57,963 46,440 Software licenses 14,400 12,169 51,197 44,033 Other (b) 24,384 19,045 72,603 58,132 Total Performance Services (a) 105,556 96,903 323,860 292,962 Total segment net revenue 322,241 347,842 995,759 1,092,213 Eliminations (a) (9) (9) (28) (18) Net revenue $ 322,232 $ 347,833 $ 995,731 $ 1,092,195 _________________________________ (a) Includes intersegment revenue that is eliminated in consolidation. Intersegment revenue is not separately identified in Segments as the amounts are not material. (b) Includes revenue from Contigo Health, Remitra and other PINC AI revenue. Additional segment information related to depreciation and amortization expense, capital expenditures and total assets was as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Depreciation and amortization expense (a) : Supply Chain Services $ 13,002 $ 14,114 $ 40,862 $ 40,710 Performance Services 17,189 16,163 53,407 48,349 Corporate 2,000 2,282 6,299 6,705 Total depreciation and amortization expense $ 32,191 $ 32,559 $ 100,568 $ 95,764 Capital expenditures: Supply Chain Services $ 6,571 $ 6,740 $ 19,586 $ 22,212 Performance Services 13,311 10,926 38,576 34,312 Corporate 166 735 302 4,537 Total capital expenditures $ 20,048 $ 18,401 $ 58,464 $ 61,061 March 31, 2023 June 30, 2022 Total assets: Supply Chain Services $ 1,355,552 $ 1,406,108 Performance Services 1,261,241 1,054,687 Corporate 896,047 896,336 Total assets 3,512,840 3,357,131 Eliminations (b) (323) (4) Total assets, net $ 3,512,517 $ 3,357,127 _________________________________ (a) Includes amortization of purchased intangible assets. (b) Includes eliminations of intersegment transactions which occur during the ordinary course of business. The Company uses Segment Adjusted EBITDA (a financial measure not determined in accordance with generally accepted accounting principles (“Non-GAAP”)) as its primary measure of profit or loss to assess segment performance and to determine the allocation of resources. The Company also uses Segment Adjusted EBITDA to facilitate the comparison of the segment operating performance on a consistent basis from period to period. The Company defines Segment Adjusted EBITDA as the segment’s net revenue less cost of revenue and operating expenses directly attributable to the segment excluding depreciation and amortization, amortization of purchased intangible assets, merger and acquisition-related expense and non-recurring or non-cash items and including equity in net income of unconsolidated affiliates. Operating expenses directly attributable to the segment include expenses associated with sales and marketing, general and administrative and product development activities specific to the operation of each segment. General and administrative corporate expenses that are not specific to a particular segment are not included in the calculation of Segment Adjusted EBITDA. Segment Adjusted EBITDA also excludes any income and expense that has been classified as discontinued operations. For more information on Segment Adjusted EBITDA and the use of Non-GAAP financial measures, see “Our Use of Non-GAAP Financial Measures” within Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations. A reconciliation of income before income taxes to unaudited Segment Adjusted EBITDA, a Non-GAAP financial measure, is as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Income before income taxes $ 65,881 $ 53,763 $ 215,748 $ 277,701 Equity in net income of unconsolidated affiliates (a) (4,630) (3,991) (14,547) (17,165) Interest expense, net 4,269 2,804 11,759 8,465 Gain on FFF Put and Call Rights (b) — — — (64,110) Other (income) expense, net (2,954) 4,248 (3,720) 2,176 Operating income 62,566 56,824 209,240 207,067 Depreciation and amortization 20,275 21,408 65,153 62,874 Amortization of purchased intangible assets 11,916 11,151 35,415 32,890 Stock-based compensation (c) 6,709 14,149 16,859 38,229 Acquisition- and disposition-related expenses 6,294 3,115 11,592 10,282 Strategic initiative and financial restructuring-related expenses 1,942 5,540 10,988 9,314 Equity in net income of unconsolidated affiliates (a) 4,630 3,991 14,547 17,165 Deferred compensation plan expense (income) (d) 2,859 (3,994) 3,148 (1,923) Other reconciling items, net 95 4 260 9 Non-GAAP Adjusted EBITDA $ 117,286 $ 112,188 $ 367,202 $ 375,907 Segment Non-GAAP Adjusted EBITDA: Supply Chain Services (e) $ 122,040 $ 118,034 $ 371,228 $ 381,586 Performance Services (e) 25,018 26,552 87,587 89,277 Corporate (29,772) (32,398) (91,613) (94,956) Non-GAAP Adjusted EBITDA $ 117,286 $ 112,188 $ 367,202 $ 375,907 _________________________________ (a) Refer to Note 4 - Investments for more information. (b) Refer to Note 5 - Fair Value Measurements for more information. (c) Includes non-cash employee stock-based compensation expense and stock purchase plan expense of $0.1 million for both the three months ended March 31, 2023 and 2022 and $0.5 million and $0.4 million for the nine months ended March 31, 2023 and 2022, respectively. (d) Represents realized and unrealized gains and (losses) and dividend income on deferred compensation plan assets. (e) Includes intersegment revenue which is eliminated in consolidation.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which the Company exercised control and when applicable, entities for which the Company had a controlling financial interest or was the primary beneficiary. All intercompany transactions have been eliminated upon consolidation. Accordingly, certain information and disclosures normally included in annual financial statements have been condensed or omitted. The accompanying condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of results of operations and financial condition for the interim periods shown, consisting of normal recurring adjustments, unless otherwise disclosed. The Company believes that the disclosures are adequate to make the information presented not misleading and should be read in conjunction with the audited consolidated financial statements and related footnotes contained in the 2022 Annual Report.
Use of Estimates in the Preparation of Financial Statements	Use of Estimates in the Preparation of Financial Statements The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. Significant estimates are evaluated on an ongoing basis, including, but not limited to, estimates for net administrative fees revenue, software licenses, other services and support revenue, contract assets, deferred revenue, contract costs, allowances for credit losses, reserves for net realizable value of inventory, obsolete inventory, useful lives of property and equipment, stock-based compensation, deferred tax balances including valuation allowances on deferred tax assets, uncertain tax positions, values of investments not publicly traded, projected future cash flows used in the evaluation of asset impairments, values of call rights, values of earn-out liabilities and the allocation of purchase prices. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, (“ASU 2021-08”), which requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 during the second quarter of fiscal 2023. The standard did not have a material impact on the Company’s financial statements nor its related disclosures.

ORGANIZATION (Tables)

ORGANIZATION (Tables)	9 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Supplemental Cash Flow Information	The following table presents supplementary cash flows information for the nine months ended March 31, 2023 and 2022 (in thousands): Nine Months Ended March 31, 2023 2022 Supplemental schedule of non-cash investing and financing activities: Non-cash additions to property and equipment $ 5 $ 129 Non-cash investment in unconsolidated affiliates 7,800 — Accrued dividend equivalents 778 738

INVESTMENTS (Tables)

INVESTMENTS (Tables)	9 Months Ended
	Mar. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
Schedule of Investments in Unconsolidated Affiliates	The Company’s investments in unconsolidated affiliates consisted of the following (in thousands): Equity in Net Income Three Months Ended Nine Months Ended Carrying Value March 31, March 31, March 31, 2023 June 30, 2022 2023 2022 2023 2022 FFF $ 136,584 $ 137,162 $ 1,370 $ 2,437 $ 9,075 $ 11,836 Exela 31,368 27,733 2,865 501 3,635 1,504 Qventus 16,000 16,000 — — — — Prestige 16,206 15,597 139 935 610 3,272 Other investments 30,142 19,053 256 118 1,227 553 Total investments $ 230,300 $ 215,545 $ 4,630 $ 3,991 $ 14,547 $ 17,165

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities	The following table represents the Company’s financial assets and liabilities, which are measured at fair value on a recurring basis (in thousands): Fair Value of Financial Assets and Liabilities Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs March 31, 2023 Cash equivalents $ 76 $ 76 $ — $ — Deferred compensation plan assets 52,787 52,787 — — Total assets 52,863 52,863 — — Earn-out liabilities 27,174 — — 27,174 Total liabilities $ 27,174 $ — $ — $ 27,174 June 30, 2022 Cash equivalents $ 75 $ 75 $ — $ — Deferred compensation plan assets 52,718 52,718 — — Total assets 52,793 52,793 — — Earn-out liabilities 22,789 — — 22,789 Total liabilities $ 22,789 $ — $ — $ 22,789
Schedule of Fair Value Measurement Inputs and Valuation Assumptions	Input assumptions As of March 31, 2023 As of June 30, 2022 Probability of transferred member renewal percentage < 50% 5.0 % 5.0 % Probability of transferred member renewal percentage between 50% and 65% 10.0 % 10.0 % Probability of transferred member renewal percentage between 65% and 80% 25.0 % 25.0 % Probability of transferred member renewal percentage > 80% 60.0 % 60.0 % Credit spread 1.8 % 1.6 % _________________________________ (a) The Acurity and Nexera earn-out liability was initially valued as of February 28, 2020.
Schedule of Reconciliation of Earn-out Liabilities and FFF Put Rights	A reconciliation of the Company’s earn-out liabilities and FFF Put Right is as follows (in thousands): Beginning Balance Purchases (Settlements) (a) (Gain)/Loss (b) Ending Balance Three Months Ended March 31, 2023 Earn-out liabilities $ 24,098 $ — $ 3,076 $ 27,174 Total Level 3 liabilities $ 24,098 $ — $ 3,076 $ 27,174 Three Months Ended March 31, 2022 Earn-out liabilities $ 24,139 $ — $ (945) $ 23,194 Total Level 3 liabilities $ 24,139 $ — $ (945) $ 23,194 Nine Months Ended March 31, 2023 Earn-out liabilities $ 22,789 $ 1,460 $ 2,925 $ 27,174 Total Level 3 liabilities $ 22,789 $ 1,460 $ 2,925 $ 27,174 Nine Months Ended March 31, 2022 Earn-out liabilities $ 24,249 $ — $ (1,055) $ 23,194 FFF put right 64,110 (64,110) — — Total Level 3 liabilities $ 88,359 $ (64,110) $ (1,055) $ 23,194 _________________________________ (a) Purchases for the nine months ended March 31, 2023 includes an earn-out which has not been earned or paid as of March 31, 2023. Settlements for the nine months ended March 31, 2022 includes non-cash gain recognized as a result the termination of the FFF Put Right and the derecognition of the FFF Put Right liability. (b) A gain on level 3 liability balances will decrease the liability ending balance whereas a loss on level 3 liability balance will increase the liability ending balance.
Schedule of Reconciliation of FFF Call Rights	A reconciliation of the Company’s earn-out liabilities and FFF Put Right is as follows (in thousands): Beginning Balance Purchases (Settlements) (a) (Gain)/Loss (b) Ending Balance Three Months Ended March 31, 2023 Earn-out liabilities $ 24,098 $ — $ 3,076 $ 27,174 Total Level 3 liabilities $ 24,098 $ — $ 3,076 $ 27,174 Three Months Ended March 31, 2022 Earn-out liabilities $ 24,139 $ — $ (945) $ 23,194 Total Level 3 liabilities $ 24,139 $ — $ (945) $ 23,194 Nine Months Ended March 31, 2023 Earn-out liabilities $ 22,789 $ 1,460 $ 2,925 $ 27,174 Total Level 3 liabilities $ 22,789 $ 1,460 $ 2,925 $ 27,174 Nine Months Ended March 31, 2022 Earn-out liabilities $ 24,249 $ — $ (1,055) $ 23,194 FFF put right 64,110 (64,110) — — Total Level 3 liabilities $ 88,359 $ (64,110) $ (1,055) $ 23,194 _________________________________ (a) Purchases for the nine months ended March 31, 2023 includes an earn-out which has not been earned or paid as of March 31, 2023. Settlements for the nine months ended March 31, 2022 includes non-cash gain recognized as a result the termination of the FFF Put Right and the derecognition of the FFF Put Right liability. (b) A gain on level 3 liability balances will decrease the liability ending balance whereas a loss on level 3 liability balance will increase the liability ending balance.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	9 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill consisted of the following (in thousands): Supply Chain Services Performance Services Total June 30, 2022 $ 388,502 $ 611,411 $ 999,913 Acquisition of businesses and assets — 69,160 69,160 March 31, 2023 $ 388,502 $ 680,571 $ 1,069,073
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): Useful Life March 31, 2023 June 30, 2022 Member relationships 14.7 years $ 386,100 $ 386,100 Provider network 15.0 years 106,500 — Technology 7.1 years 99,317 98,017 Customer relationships 9.4 years 57,930 47,830 Non-compete agreements 5.2 years 17,715 17,315 Trade names 6.7 years 18,920 17,210 Other (a) 9.3 years 9,233 7,682 Total intangible assets 695,715 574,154 Accumulated amortization (252,997) (217,582) Total intangible assets, net $ 442,718 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. The net carrying value of intangible assets by segment was as follows (in thousands): March 31, 2023 June 30, 2022 Supply Chain Services $ 277,641 $ 301,611 Performance Services (a) 165,077 54,961 Total intangible assets, net $ 442,718 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset.
Schedule of Indefinite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): Useful Life March 31, 2023 June 30, 2022 Member relationships 14.7 years $ 386,100 $ 386,100 Provider network 15.0 years 106,500 — Technology 7.1 years 99,317 98,017 Customer relationships 9.4 years 57,930 47,830 Non-compete agreements 5.2 years 17,715 17,315 Trade names 6.7 years 18,920 17,210 Other (a) 9.3 years 9,233 7,682 Total intangible assets 695,715 574,154 Accumulated amortization (252,997) (217,582) Total intangible assets, net $ 442,718 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. The net carrying value of intangible assets by segment was as follows (in thousands): March 31, 2023 June 30, 2022 Supply Chain Services $ 277,641 $ 301,611 Performance Services (a) 165,077 54,961 Total intangible assets, net $ 442,718 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset.
Schedule of Estimated Aggregate Amortization Expense	The estimated amortization expense for each of the next five fiscal years and thereafter is as follows (in thousands): 2023 (a) $ 12,688 2024 49,761 2025 48,136 2026 46,892 2027 44,240 Thereafter 240,001 Total amortization expense $ 441,718 (a) As of March 31, 2023, estimated amortization expense is for the period from April 1, 2023 to June 30, 2023.

DEBT AND NOTES PAYABLE (Tables)

DEBT AND NOTES PAYABLE (Tables)	9 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Long-Term Debt and Notes Payable	Long-term debt and notes payable consisted of the following (in thousands): March 31, 2023 June 30, 2022 Credit facility $ 235,000 $ 150,000 Notes payable to members, net of discount 225,814 298,994 Other notes payable 2,280 5,333 Total debt and notes payable 463,094 454,327 Less: current portion (335,472) (250,859) Total long-term debt and notes payable $ 127,622 $ 203,468

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	9 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Reconciliation of Common Shares Used for Earnings Per Share	The following table provides a reconciliation of the numerator and denominator used for basic and diluted earnings per share (in thousands, except per share amounts): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Numerator for basic earnings per share: Net income attributable to stockholders (a) $ 46,801 $ 38,415 $ 153,563 $ 235,964 Numerator for diluted earnings per share: Net income attributable to stockholders (a) $ 46,801 $ 38,415 $ 153,563 $ 235,964 Net loss attributable to non-controlling interest — — — 1,643 Net income for diluted earnings per share $ 46,801 $ 38,415 $ 153,563 $ 237,607 Denominator for earnings per share: Basic weighted average shares outstanding (b) 118,872 118,697 118,668 120,957 Effect of dilutive securities: (c) Stock options 76 98 103 225 Restricted stock 528 465 519 499 Performance share awards 340 553 542 621 Diluted weighted average shares and assumed conversions 119,816 119,813 119,832 122,302 Earnings per share attributable to stockholders: Basic $ 0.39 $ 0.32 $ 1.29 $ 1.95 Diluted $ 0.39 $ 0.32 $ 1.28 $ 1.94 _________________________________ (a) Net income attributable to stockholders was calculated as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Net income $ 48,649 $ 39,069 $ 155,982 $ 237,607 Net income attributable to non-controlling interest (1,848) (654) (2,419) (1,643) Net income attributable to stockholders $ 46,801 $ 38,415 $ 153,563 $ 235,964 (b) Weighted average number of common shares used for basic earnings per share excludes the impact of all potentially issuable dilutive shares of Class A common stock for the three and nine months ended March 31, 2023 and 2022. (c) The effect of 0.3 million stock options and restricted stock units were excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect for both the three and nine months ended March 31, 2023. Additionally, for the three and nine months ended March 31, 2023, the effect of 0.4 million and 0.3 million performance share awards, respectively, was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period. For the three and nine months ended March 31, 2022, the effect of 0.3 million and 0.6 million stock options and restricted stock units, respectively, was excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect. Additionally, for the nine months ended March 31, 2022, the effect of 0.3 million performance share awards was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period.

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-Based Compensation Expense and Resulting Tax Benefits	Stock-based compensation expense and the resulting deferred tax benefits were as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Pre-tax stock-based compensation expense $ 6,560 $ 14,004 $ 16,375 $ 37,792 Less: deferred tax benefit (a) 2,400 3,288 4,407 8,013 Total stock-based compensation expense, net of tax $ 4,160 $ 10,716 $ 11,968 $ 29,779 _________________________________ (a) For the three and nine months ended March 31, 2023, the deferred tax benefit was reduced by $0.7 million and $0.2 million, respectively, attributable to stock-based compensation expense that is nondeductible for tax purposes pursuant to Section 162(m) as amended by the Tax Cuts and Jobs Act of 2017.
Schedule of Information Related to Restricted Stock	The following table includes information related to restricted stock, performance share awards and stock options for the nine months ended March 31, 2023: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 419,519 36.69 823,009 35.34 — — Vested/exercised (257,571) 36.37 (826,743) 36.35 (24,351) 32.84 Forfeited (72,268) 35.81 (81,350) 33.41 (2,906) 35.65 Outstanding at March 31, 2023 1,290,810 $ 35.78 1,493,711 $ 33.09 869,097 $ 30.30 Stock options outstanding and exercisable at March 31, 2023 869,097 $ 30.30
Schedule of Information Related to Performance Share Awards	The following table includes information related to restricted stock, performance share awards and stock options for the nine months ended March 31, 2023: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 419,519 36.69 823,009 35.34 — — Vested/exercised (257,571) 36.37 (826,743) 36.35 (24,351) 32.84 Forfeited (72,268) 35.81 (81,350) 33.41 (2,906) 35.65 Outstanding at March 31, 2023 1,290,810 $ 35.78 1,493,711 $ 33.09 869,097 $ 30.30 Stock options outstanding and exercisable at March 31, 2023 869,097 $ 30.30
Schedule of Information Related to Stock Options	The following table includes information related to restricted stock, performance share awards and stock options for the nine months ended March 31, 2023: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 419,519 36.69 823,009 35.34 — — Vested/exercised (257,571) 36.37 (826,743) 36.35 (24,351) 32.84 Forfeited (72,268) 35.81 (81,350) 33.41 (2,906) 35.65 Outstanding at March 31, 2023 1,290,810 $ 35.78 1,493,711 $ 33.09 869,097 $ 30.30 Stock options outstanding and exercisable at March 31, 2023 869,097 $ 30.30
Schedule of Unrecognized Stock-Based Compensation Expense	Unrecognized stock-based compensation expense at March 31, 2023 was as follows (in thousands): Unrecognized Stock-Based Compensation Expense Weighted Average Amortization Period Restricted stock $ 23,381 1.8 years Performance share awards 22,830 1.8 years Total unrecognized stock-based compensation expense $ 46,211 1.8 years
Schedule of Aggregate Intrinsic Value of Stock Options	The aggregate intrinsic value of stock options at March 31, 2023 was as follows (in thousands): Intrinsic Value of Stock Options Outstanding and exercisable $ 2,325 Exercised during the nine months ended March 31, 2023 78

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases	Future minimum lease payments under noncancellable operating leases with initial lease terms in excess of one year were as follows (in thousands): March 31, 2023 June 30, 2022 2023 (a) $ 2,406 $ 12,131 2024 12,381 12,267 2025 12,389 12,301 2026 9,005 9,005 2027 1,324 1,323 Total future minimum lease payments 37,505 47,027 Less: imputed interest 2,281 3,445 Total operating lease liabilities (b) $ 35,224 $ 43,582 _________________________________ (a) As of March 31, 2023, future minimum lease payments are for the period from April 1, 2023 to June 30, 2023. (b) As of March 31, 2023, total operating lease liabilities included $9.8 million within other current liabilities in the Condensed Consolidated Balance Sheets.

SEGMENTS (Tables)

SEGMENTS (Tables)	9 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of Segment Information	The following table presents disaggregated revenue by business segment and underlying source (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Net revenue: Supply Chain Services Net administrative fees $ 148,441 $ 148,396 $ 452,870 $ 448,261 Software licenses, other services and support 11,032 8,914 35,963 27,165 Services and software licenses 159,473 157,310 488,833 475,426 Products 57,212 93,629 183,066 323,825 Total Supply Chain Services (a) 216,685 250,939 671,899 799,251 Performance Services Software licenses, other services and support SaaS-based products subscriptions 44,685 49,347 142,097 144,357 Consulting services 22,087 16,342 57,963 46,440 Software licenses 14,400 12,169 51,197 44,033 Other (b) 24,384 19,045 72,603 58,132 Total Performance Services (a) 105,556 96,903 323,860 292,962 Total segment net revenue 322,241 347,842 995,759 1,092,213 Eliminations (a) (9) (9) (28) (18) Net revenue $ 322,232 $ 347,833 $ 995,731 $ 1,092,195 _________________________________ (a) Includes intersegment revenue that is eliminated in consolidation. Intersegment revenue is not separately identified in Segments as the amounts are not material. (b) Includes revenue from Contigo Health, Remitra and other PINC AI revenue. Additional segment information related to depreciation and amortization expense, capital expenditures and total assets was as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Depreciation and amortization expense (a) : Supply Chain Services $ 13,002 $ 14,114 $ 40,862 $ 40,710 Performance Services 17,189 16,163 53,407 48,349 Corporate 2,000 2,282 6,299 6,705 Total depreciation and amortization expense $ 32,191 $ 32,559 $ 100,568 $ 95,764 Capital expenditures: Supply Chain Services $ 6,571 $ 6,740 $ 19,586 $ 22,212 Performance Services 13,311 10,926 38,576 34,312 Corporate 166 735 302 4,537 Total capital expenditures $ 20,048 $ 18,401 $ 58,464 $ 61,061 March 31, 2023 June 30, 2022 Total assets: Supply Chain Services $ 1,355,552 $ 1,406,108 Performance Services 1,261,241 1,054,687 Corporate 896,047 896,336 Total assets 3,512,840 3,357,131 Eliminations (b) (323) (4) Total assets, net $ 3,512,517 $ 3,357,127 _________________________________ (a) Includes amortization of purchased intangible assets. (b) Includes eliminations of intersegment transactions which occur during the ordinary course of business.
Schedule of Reconciliation of Income Before Income Taxes to Segment Adjusted EBITDA	A reconciliation of income before income taxes to unaudited Segment Adjusted EBITDA, a Non-GAAP financial measure, is as follows (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Income before income taxes $ 65,881 $ 53,763 $ 215,748 $ 277,701 Equity in net income of unconsolidated affiliates (a) (4,630) (3,991) (14,547) (17,165) Interest expense, net 4,269 2,804 11,759 8,465 Gain on FFF Put and Call Rights (b) — — — (64,110) Other (income) expense, net (2,954) 4,248 (3,720) 2,176 Operating income 62,566 56,824 209,240 207,067 Depreciation and amortization 20,275 21,408 65,153 62,874 Amortization of purchased intangible assets 11,916 11,151 35,415 32,890 Stock-based compensation (c) 6,709 14,149 16,859 38,229 Acquisition- and disposition-related expenses 6,294 3,115 11,592 10,282 Strategic initiative and financial restructuring-related expenses 1,942 5,540 10,988 9,314 Equity in net income of unconsolidated affiliates (a) 4,630 3,991 14,547 17,165 Deferred compensation plan expense (income) (d) 2,859 (3,994) 3,148 (1,923) Other reconciling items, net 95 4 260 9 Non-GAAP Adjusted EBITDA $ 117,286 $ 112,188 $ 367,202 $ 375,907 Segment Non-GAAP Adjusted EBITDA: Supply Chain Services (e) $ 122,040 $ 118,034 $ 371,228 $ 381,586 Performance Services (e) 25,018 26,552 87,587 89,277 Corporate (29,772) (32,398) (91,613) (94,956) Non-GAAP Adjusted EBITDA $ 117,286 $ 112,188 $ 367,202 $ 375,907 _________________________________ (a) Refer to Note 4 - Investments for more information. (b) Refer to Note 5 - Fair Value Measurements for more information. (c) Includes non-cash employee stock-based compensation expense and stock purchase plan expense of $0.1 million for both the three months ended March 31, 2023 and 2022 and $0.5 million and $0.4 million for the nine months ended March 31, 2023 and 2022, respectively. (d) Represents realized and unrealized gains and (losses) and dividend income on deferred compensation plan assets. (e) Includes intersegment revenue which is eliminated in consolidation.

ORGANIZATION - Narrative (Detai

ORGANIZATION - Narrative (Details)	9 Months Ended
	Mar. 31, 2023 segment brand
Segment Reporting Information [Line Items]
Number of business segments | segment	2
Performance Services
Segment Reporting Information [Line Items]
Number of sub-brands | brand	3

ORGANIZATION - Supplementary Ca

ORGANIZATION - Supplementary Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Supplemental schedule of non-cash investing and financing activities:
Non-cash additions to property and equipment	$ 5	$ 129
Non-cash investment in unconsolidated affiliates	7,800	0
Accrued dividend equivalents	$ 778	$ 738

BUSINESS ACQUISITIONS (Details)

BUSINESS ACQUISITIONS (Details) $ in Thousands	Oct. 13, 2022 USD ($) provider	Mar. 31, 2023 USD ($)	Jun. 30, 2022 USD ($)
Asset Acquisition, Contingent Consideration [Line Items]
Goodwill		$ 1,069,073	$ 999,913
TRPN Transferred Assets
Asset Acquisition, Contingent Consideration [Line Items]
Number of TRPN contracts | provider	900,000
Transferring cash	$ 177,500
Escrow account satisfy indemnification obligations	17,800
Fair value of intangible assets acquired	116,600
Goodwill	$ 60,900

INVESTMENTS - Schedule of Inves

INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Schedule of Equity Method Investments [Line Items]
Carrying Value	$ 230,300		$ 230,300		$ 215,545
Equity in Net Income	4,630	$ 3,991	14,547	$ 17,165
FFF
Schedule of Equity Method Investments [Line Items]
Carrying Value	136,584		136,584		137,162
Equity in Net Income	1,370	2,437	9,075	11,836
Exela
Schedule of Equity Method Investments [Line Items]
Carrying Value	31,368		31,368		27,733
Equity in Net Income	2,865	501	3,635	1,504
Qventus
Schedule of Equity Method Investments [Line Items]
Carrying Value	16,000		16,000		16,000
Equity in Net Income	0	0	0	0
Prestige
Schedule of Equity Method Investments [Line Items]
Carrying Value	16,206		16,206		15,597
Equity in Net Income	139	935	610	3,272
Other investments
Schedule of Equity Method Investments [Line Items]
Carrying Value	30,142		30,142		$ 19,053
Equity in Net Income	$ 256	$ 118	$ 1,227	$ 553

INVESTMENTS - Narrative (Detail

INVESTMENTS - Narrative (Details) $ in Millions	Mar. 03, 2023 USD ($)	Mar. 31, 2023 health_system	Jun. 30, 2022
FFF
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)		49%	49%
Liquidation preference value | $	$ 32.3
FFF | Class B Common Stock
Schedule of Equity Method Investments [Line Items]
Increase in liquidation preference | $	$ 24.8
ExPre Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)		15%
Number of member health systems | health_system		11
PRAM Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)		26%
Number of member health systems | health_system		16
Qventus
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)		7%
ExPre Holdings, LLC | Exela
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)		6%
PRAM Holdings, LLC | Prestige
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)		20%

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities (Details) - Recurring - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 76	$ 75
Deferred compensation plan assets	52,787	52,718
Total assets	52,863	52,793
Earn-out liabilities	27,174	22,789
Total liabilities	27,174	22,789
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	76	75
Deferred compensation plan assets	52,787	52,718
Total assets	52,863	52,793
Earn-out liabilities	0	0
Total liabilities	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Deferred compensation plan assets	0	0
Total assets	0	0
Earn-out liabilities	0	0
Total liabilities	0	0
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Deferred compensation plan assets	0	0
Total assets	0	0
Earn-out liabilities	27,174	22,789
Total liabilities	$ 27,174	$ 22,789

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details)	9 Months Ended
	Mar. 31, 2023 USD ($)	Jun. 30, 2022 USD ($)	Aug. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assumed market interest rate (percent)	1.60%	1.60%
Notes payable to members, net of discount | Notes Payable, Other Payables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Imputed interest (percent)			1.80%
Debt discount	$ 5,200,000	$ 9,100,000
Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	23,000,000	22,800,000
Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”) | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	$ 0	$ 30,000,000
Credit spread | Valuation Technique, Estimated Future Earnings | Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out input assumptions (percent)	0.018	0.016
FFF Call Right
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Call right, exercisable term, key event (in days)	180 days
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FFF call right	$ 0	$ 0
Earn-out liabilities	27,174,000	22,789,000
Level 1 | Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	0	0
Level 1 | Prepaid Expenses and Other Current Assets | Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Current portion of deferred compensation plan assets	5,100,000	5,300,000
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Imputed interest (percent)			1.80%
Notes payable, difference between fair value and carrying value		100,000
Level 2 | Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Fair

FAIR VALUE MEASUREMENTS - Fair Value Measurement Input Assumptions (Details) - Valuation Technique, Estimated Future Earnings - Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”)	Mar. 31, 2023	Jun. 30, 2022
Probability of transferred member renewal percentage less than 50%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.050	0.050
Probability of transferred member renewal percentage between 50% and 65%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.100	0.100
Probability of transferred member renewal percentage between 65% and 80%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.250	0.250
Probability of transferred member renewal percentage greater than 80%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.600	0.600
Credit spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.018	0.016

FAIR VALUE MEASUREMENTS - Recon

FAIR VALUE MEASUREMENTS - Reconciliation of Earn-Out Liabilities and FFF Put and Call Rights (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	$ 24,098	$ 24,139	$ 22,789	$ 88,359
Purchases (Settlements)	0	0	1,460	(64,110)
(Gain) Loss	3,076	(945)	2,925	(1,055)
Ending Balance	$ 27,174	$ 23,194	$ 27,174	$ 23,194
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Nonoperating Income (Expense)	Nonoperating Income (Expense)	Nonoperating Income (Expense)	Nonoperating Income (Expense)
Earn-out liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	$ 24,098	$ 24,139	$ 22,789	$ 24,249
Purchases (Settlements)	0	0	1,460	0
(Gain) Loss	3,076	(945)	2,925	(1,055)
Ending Balance	$ 27,174	23,194	$ 27,174	23,194
FFF put right
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance				64,110
Purchases (Settlements)				(64,110)
(Gain) Loss				0
Ending Balance		$ 0		$ 0

CONTRACT BALANCES - Contract As

CONTRACT BALANCES - Contract Assets, Deferred Revenue and Capitalized Contract Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized			$ 25.5
Revenue recognized from performance obligations satisfied in previous periods	$ 5.4	$ 5.7	3.9	$ 3.6
Revenue recognized associated with revised forecasts underlying contracts with variable consideration components	(0.7)	0.3	(2.7)	0.3
Administrative Fees
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized associated with a change in net administration fee revenue	$ 6.1	$ 5.4	$ 6.6	$ 3.3

CONTRACT BALANCES - Remaining P

CONTRACT BALANCES - Remaining Performance Obligation (Details) $ in Millions	Mar. 31, 2023 USD ($)
Revenue from Contract with Customer [Abstract]
Transaction price allocated to remaining performance obligation	$ 701.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation to be satisfied (percent)	40%
Remaining performance obligation satisfaction period (in months)	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation to be satisfied (percent)	23%
Remaining performance obligation satisfaction period (in months)	12 months

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill beginning balance	$ 999,913
Acquisition of businesses and assets	69,160
Goodwill ending balance	1,069,073
Supply Chain Services
Goodwill [Roll Forward]
Goodwill beginning balance	388,502
Acquisition of businesses and assets	0
Goodwill ending balance	388,502
Performance Services
Goodwill [Roll Forward]
Goodwill beginning balance	611,411
Acquisition of businesses and assets	69,160
Goodwill ending balance	$ 680,571

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Total intangible assets	$ 695,715	$ 574,154
Accumulated amortization	(252,997)	(217,582)
Total intangible assets, net	442,718	356,572
Other
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset	$ 1,000
Member relationships
Finite-Lived Intangible Assets [Line Items]
Useful Life	14 years 8 months 12 days
Total intangible assets	$ 386,100	386,100
Provider network
Finite-Lived Intangible Assets [Line Items]
Useful Life	15 years
Total intangible assets	$ 106,500	0
Technology
Finite-Lived Intangible Assets [Line Items]
Useful Life	7 years 1 month 6 days
Total intangible assets	$ 99,317	98,017
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Useful Life	9 years 4 months 24 days
Total intangible assets	$ 57,930	47,830
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Useful Life	5 years 2 months 12 days
Total intangible assets	$ 17,715	17,315
Trade names
Finite-Lived Intangible Assets [Line Items]
Useful Life	6 years 8 months 12 days
Total intangible assets	$ 18,920	17,210
Other
Finite-Lived Intangible Assets [Line Items]
Useful Life	9 years 3 months 18 days
Total intangible assets	$ 9,233	$ 7,682

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS - Intangible Assets by Segment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, net	$ 442,718	$ 356,572
Other
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset	1,000
Supply Chain Services
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, net	277,641	301,611
Performance Services
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, net	$ 165,077	$ 54,961

GOODWILL AND INTANGIBLE ASSET_5

GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Oct. 13, 2022	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Goodwill [Line Items]
Intangible asset amortization		$ 11,916	$ 11,151	$ 35,415	$ 32,890
TRPN Transferred Assets
Goodwill [Line Items]
Fair value of intangible assets acquired	$ 116,600
Weighted average useful life of the acquired intangible assets	14 years 1 month 6 days
TRPN Transferred Assets | Provider network
Goodwill [Line Items]
Fair value of intangible assets acquired	$ 106,500
Weighted average useful life of the acquired intangible assets	15 years

GOODWILL AND INTANGIBLE ASSET_6

GOODWILL AND INTANGIBLE ASSETS - Schedule of Estimated Aggregate Amortization Expense (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 12,688
2024	49,761
2025	48,136
2026	46,892
2027	44,240
Thereafter	240,001
Total intangible assets, net	$ 441,718

DEBT AND NOTES PAYABLE - Schedu

DEBT AND NOTES PAYABLE - Schedule of Long-Term Debt and Notes Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Debt Instrument [Line Items]
Total debt and notes payable	$ 463,094	$ 454,327
Less: current portion	(335,472)	(250,859)
Total long-term debt and notes payable	127,622	203,468
Credit facility
Debt Instrument [Line Items]
Total debt and notes payable	235,000	150,000
Notes Payable | Notes payable to members, net of discount
Debt Instrument [Line Items]
Total debt and notes payable	225,814	298,994
Notes Payable | Other notes payable
Debt Instrument [Line Items]
Total debt and notes payable	$ 2,280	$ 5,333

DEBT AND NOTES PAYABLE - Credit

DEBT AND NOTES PAYABLE - Credit Facility (Narrative) (Details)		1 Months Ended	4 Months Ended	9 Months Ended
	Dec. 12, 2022 USD ($) extension	Apr. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Nov. 09, 2018 USD ($)
Line of Credit Facility [Line Items]
Outstanding borrowings			$ 463,094,000	$ 463,094,000		$ 454,327,000
Proceeds from credit facility				350,000,000	$ 300,000,000
Payments on credit facility				$ 265,000,000	$ 125,000,000
Credit facility
Line of Credit Facility [Line Items]
Number of available extensions | extension	2
Duration of each available extension	1 year
Maximum borrowing capacity	$ 1,000,000,000						$ 1,000,000,000
Additional borrowing capacity	350,000,000
Debt instrument carrying amount	331,300,000
Credit facility, unused capacity commitment fee (percent)			0.125%
Weighted average interest rate			6.195%	6.195%
Indebtedness or guarantee threshold	$ 75,000,000
Outstanding borrowings			$ 235,000,000	$ 235,000,000
Available borrowing capacity			$ 765,000,000	765,000,000
Proceeds from credit facility				65,000,000
Payments on credit facility				$ 130,000,000
Credit facility | Subsequent Event
Line of Credit Facility [Line Items]
Payments on credit facility		$ 60,000,000
Credit facility | Minimum
Line of Credit Facility [Line Items]
Credit facility, unused capacity commitment fee (percent)			0.125%
Credit facility | Maximum
Line of Credit Facility [Line Items]
Credit facility, unused capacity commitment fee (percent)			0.225%
Credit facility | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.10%
Interest rate (percent)			6.152%	6.152%
Credit facility | SOFR | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.25%
Credit facility | SOFR | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.75%
Credit facility | Fed Funds Effective Rate Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.50%
Credit facility | One-Month Adjusted Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	1%
Credit facility | Base Rate
Line of Credit Facility [Line Items]
Debt instrument, interest rate, stated percentage	0%
Interest rate (percent)			8.25%	8.25%
Credit facility | Base Rate | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.25%
Credit facility | Base Rate | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.75%
Letters of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 50,000,000
Swing Line Loan
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 100,000,000
Prior Loan Agreement
Line of Credit Facility [Line Items]
Proceeds from credit facility				$ 285,000,000
Payments on credit facility				$ 135,000,000

DEBT AND NOTES PAYABLE - Notes

DEBT AND NOTES PAYABLE - Notes Payable (Narrative) (Details) - Notes Payable - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2023	Jun. 30, 2022	Aug. 31, 2020
Minimum
Debt Instrument [Line Items]
Notes payable, stated maturity period	3 years
Maximum
Debt Instrument [Line Items]
Notes payable, stated maturity period	5 years
Notes payable to members, net of discount
Debt Instrument [Line Items]
Notes payable	$ 225.8	$ 299
Debt discount	5.2	9.1
Notes payable included in current portion of long-term debt	99.2	97.8
Imputed interest (percent)			1.80%
Other notes payable
Debt Instrument [Line Items]
Notes payable	2.3	5.3
Notes payable included in current portion of long-term debt	$ 1.3	$ 3.1

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - $ / shares		3 Months Ended						9 Months Ended
	Apr. 27, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2023	Jun. 30, 2022
Subsequent Event
Class of Stock [Line Items]
Dividends declared (in dollars per share)	$ 0.21
Class A Common Stock
Class of Stock [Line Items]
Common stock outstanding (in shares)		118,880,307						118,880,307	118,052,235
Common stock, par value (in dollars per share)		$ 0.01						$ 0.01	$ 0.01
Dividends declared (in dollars per share)		$ 0.21	$ 0.21	$ 0.21	$ 0.20	$ 0.20	$ 0.20
Per share amount of dividends (in dollars per share)								$ 0.21

EARNINGS PER SHARE - Reconcilia

EARNINGS PER SHARE - Reconciliation of the Numerator and Denominator Used for Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Numerator for basic earnings per share:
Net income attributable to stockholders	$ 46,801			$ 38,415			$ 153,563	$ 235,964
Numerator for diluted earnings per share:
Net income attributable to stockholders	46,801			38,415			153,563	235,964
Net loss attributable to non-controlling interest	0			0			0	1,643
Net income for diluted earnings per share	$ 46,801			$ 38,415			$ 153,563	$ 237,607
Denominator for earnings per share:
Basic weighted average shares outstanding (in shares)	118,872			118,697			118,668	120,957
Effect of dilutive securities:
Diluted weighted average shares and assumed conversions (in shares)	119,816			119,813			119,832	122,302
Earnings per share attributable to stockholders:
Basic (in dollars per share)	$ 0.39			$ 0.32			$ 1.29	$ 1.95
Diluted (in dollars per share)	$ 0.39			$ 0.32			$ 1.28	$ 1.94
Net income	$ 48,649	$ 64,374	$ 42,959	$ 39,069	$ 77,232	$ 121,306	$ 155,982	$ 237,607
Net income attributable to non-controlling interest	(1,848)			(654)			(2,419)	(1,643)
Net income attributable to stockholders	$ 46,801			$ 38,415			$ 153,563	$ 235,964
Stock options
Effect of dilutive securities:
Effect of dilutive securities (in shares)	76			98			103	225
Restricted stock
Effect of dilutive securities:
Effect of dilutive securities (in shares)	528			465			519	499
Performance share awards
Effect of dilutive securities:
Effect of dilutive securities (in shares)	340			553			542	621
Earnings per share attributable to stockholders:
Antidilutive securities excluded from computation of earnings per share (in shares)	400						300	300
Options and Restricted Stock Units
Earnings per share attributable to stockholders:
Antidilutive securities excluded from computation of earnings per share (in shares)	300			300			300	600

STOCK-BASED COMPENSATION - Narr

STOCK-BASED COMPENSATION - Narrative (Details) - USD ($) $ in Thousands, shares in Millions	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected effective income tax rate (percent)	26%	26%
2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards authorized for grant (up to) (in shares)	14.8
Number of shares available for grant (in shares)	3.9
Unrecognized Stock-Based Compensation Expense	$ 46,211
Restricted Stock | 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 23,381
Performance share awards | 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Unrecognized Stock-Based Compensation Expense	$ 22,830
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 0
Stock options | 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Stock options, expiration period	10 years
Stock options | 2013 Equity Incentive Plan | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, expiration period	12 months
Stock options | 2013 Equity Incentive Plan | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, expiration period	90 days
Employee | Restricted Stock | 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Director | Restricted Stock | 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	1 year

STOCK-BASED COMPENSATION - Sche

STOCK-BASED COMPENSATION - Schedule of Stock-based Compensation Expense and Resulting Tax Benefits (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]
Pre-tax stock-based compensation expense	$ 6,560	$ 14,004	$ 16,375	$ 37,792
Less: deferred tax benefit	2,400	3,288	4,407	8,013
Total stock-based compensation expense, net of tax	4,160	$ 10,716	11,968	$ 29,779
Decrease in deferred tax benefit	$ 700		$ 200

STOCK-BASED COMPENSATION - Sc_2

STOCK-BASED COMPENSATION - Schedule of Information Related to Restricted Stock, Performance Share Awards and Stock Options (Details) - 2013 Equity Incentive Plan	9 Months Ended
	Mar. 31, 2023 $ / shares shares
Restricted Stock
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,201,130
Granted (in shares) | shares	419,519
Vested/exercised (in shares) | shares	(257,571)
Forfeited (in shares) | shares	(72,268)
Outstanding, ending balance (in shares) | shares	1,290,810
Weighted Average Fair Value at Grant Date
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 35.59
Granted (in dollars per share) | $ / shares	36.69
Vested/exercised (in dollars per share) | $ / shares	36.37
Forfeited (in dollars per share) | $ / shares	35.81
Outstanding, ending balance (in dollars per share) | $ / shares	$ 35.78
Performance Share Awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,578,795
Granted (in shares) | shares	823,009
Vested/exercised (in shares) | shares	(826,743)
Forfeited (in shares) | shares	(81,350)
Outstanding, ending balance (in shares) | shares	1,493,711
Weighted Average Fair Value at Grant Date
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 33.66
Granted (in dollars per share) | $ / shares	35.34
Vested/exercised (in dollars per share) | $ / shares	36.35
Forfeited (in dollars per share) | $ / shares	33.41
Outstanding, ending balance (in dollars per share) | $ / shares	$ 33.09
Stock options
Number of Options
Outstanding, beginning balance (in shares) | shares	896,354
Granted (in shares) | shares	0
Vested/exercised (in shares) | shares	(24,351)
Forfeited (in shares) | shares	(2,906)
Outstanding, ending balance (in shares) | shares	869,097
Stock options outstanding and exercisable (in shares) | shares	869,097
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 30.38
Granted (in dollars per share) | $ / shares	0
Vested/exercised (in dollars per share) | $ / shares	32.84
Forfeited (in dollars per share) | $ / shares	35.65
Outstanding, ending balance (in dollars per share) | $ / shares	30.30
Stock options outstanding and exercisable (in dollars per share) | $ / shares	$ 30.30

STOCK-BASED COMPENSATION - Sc_3

STOCK-BASED COMPENSATION - Schedule of Unrecognized Stock-Based Compensation Expense (Details) $ in Thousands	9 Months Ended
	Mar. 31, 2023 USD ($)
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 0
2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 46,211
Weighted Average Amortization Period	1 year 9 months 18 days
2013 Equity Incentive Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 23,381
Weighted Average Amortization Period	1 year 9 months 18 days
2013 Equity Incentive Plan | Performance share awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 22,830
Weighted Average Amortization Period	1 year 9 months 18 days

STOCK-BASED COMPENSATION - Sc_4

STOCK-BASED COMPENSATION - Schedule of Aggregate Intrinsic Value of Stock Options (Details) - 2013 Equity Incentive Plan $ in Thousands	9 Months Ended
	Mar. 31, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding and exercisable	$ 2,325
Exercised during the nine months ended March 31, 2023	$ 78

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Income Tax Contingency [Line Items]
Income tax expense	$ 17,232	$ 14,694	$ 59,766	$ 40,094
Effective tax rate (percent)	26%	27%	28%	14%
Tax liabilities included within other current liabilities	$ 52,300		$ 52,300
Pro Forma
Income Tax Contingency [Line Items]
Effective tax rate (percent)				25%

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Operating lease expense	$ 2,500	$ 2,500	$ 7,500	$ 7,600
Weighted average remaining lease term (in years)	3 years 1 month 6 days		3 years 1 month 6 days
Weighted average discount rate (percent)	4%		4%
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Remainder of the year	$ 2,406		$ 2,406
Year one	12,381		12,381		$ 12,131
Year two	12,389		12,389		12,267
Year three	9,005		9,005		12,301
Year four	1,324		1,324		9,005
Year five					1,323
Total future minimum lease payments	37,505		37,505		47,027
Less: imputed interest	2,281		2,281		3,445
Total operating lease liabilities	$ 35,224		$ 35,224		$ 43,582
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other current liabilities		Other current liabilities
Operating lease liability included in other liabilities, current	$ 9,800		$ 9,800

SEGMENTS - Narrative (Details)

SEGMENTS - Narrative (Details)	9 Months Ended
	Mar. 31, 2023 segment brand
Segment Reporting Information [Line Items]
Number of reportable business segments | segment	2
Performance Services
Segment Reporting Information [Line Items]
Number of sub-brands | brand	3

SEGMENTS - Schedule of Segment

SEGMENTS - Schedule of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Segment Reporting Information [Line Items]
Net revenue	$ 322,232	$ 347,833	$ 995,731	$ 1,092,195
Total depreciation and amortization expense	32,191	32,559	100,568	95,764
Total capital expenditures	20,048	18,401	58,464	61,061
Total assets	3,512,517		3,512,517		$ 3,357,127
Operating Segments
Segment Reporting Information [Line Items]
Net revenue	322,241	347,842	995,759	1,092,213
Corporate
Segment Reporting Information [Line Items]
Total depreciation and amortization expense	2,000	2,282	6,299	6,705
Total capital expenditures	166	735	302	4,537
Total assets	896,047		896,047		896,336
Eliminations
Segment Reporting Information [Line Items]
Net revenue	(9)	(9)	(28)	(18)
Total assets	(323)		(323)		(4)
Supply Chain Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	216,685	250,939	671,899	799,251
Total depreciation and amortization expense	13,002	14,114	40,862	40,710
Total capital expenditures	6,571	6,740	19,586	22,212
Total assets	1,355,552		1,355,552		1,406,108
Performance Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	105,556	96,903	323,860	292,962
Total depreciation and amortization expense	17,189	16,163	53,407	48,349
Total capital expenditures	13,311	10,926	38,576	34,312
Total assets	1,261,241		1,261,241		1,054,687
Operating Segments and Corporate Non-segment
Segment Reporting Information [Line Items]
Total assets	3,512,840		3,512,840		$ 3,357,131
Net administrative fees
Segment Reporting Information [Line Items]
Net revenue	148,441	148,396	452,870	448,261
Net administrative fees | Supply Chain Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	148,441	148,396	452,870	448,261
Software licenses, other services and support
Segment Reporting Information [Line Items]
Net revenue	116,579	105,808	359,795	320,109
Software licenses, other services and support | Supply Chain Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	11,032	8,914	35,963	27,165
Services and software licenses
Segment Reporting Information [Line Items]
Net revenue	265,020	254,204	812,665	768,370
Services and software licenses | Supply Chain Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	159,473	157,310	488,833	475,426
Products
Segment Reporting Information [Line Items]
Net revenue	57,212	93,629	183,066	323,825
Products | Supply Chain Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	57,212	93,629	183,066	323,825
SaaS-based products subscriptions | Performance Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	44,685	49,347	142,097	144,357
Consulting services | Performance Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	22,087	16,342	57,963	46,440
Software licenses | Performance Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	14,400	12,169	51,197	44,033
Other | Performance Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	$ 24,384	$ 19,045	$ 72,603	$ 58,132

SEGMENTS - Reconciliation of In

SEGMENTS - Reconciliation of Income Before Income Taxes to Segment Adjusted EBITDA (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Income before income taxes	$ 65,881	$ 53,763	$ 215,748	$ 277,701
Equity in net income of unconsolidated affiliates	(4,630)	(3,991)	(14,547)	(17,165)
Interest expense, net	4,269	2,804	11,759	8,465
Gain on FFF Put and Call Rights	0	0	0	(64,110)
Other (income) expense, net	(2,954)	4,248	(3,720)	2,176
Operating income	62,566	56,824	209,240	207,067
Depreciation and amortization	20,275	21,408	65,153	62,874
Amortization of purchased intangible assets	11,916	11,151	35,415	32,890
Stock-based compensation	6,709	14,149	16,859	38,229
Acquisition- and disposition-related expenses	6,294	3,115	11,592	10,282
Strategic initiative and financial restructuring-related expenses	1,942	5,540	10,988	9,314
Equity in net income of unconsolidated affiliates	4,630	3,991	14,547	17,165
Deferred compensation plan expense (income)	2,859	(3,994)	3,148	(1,923)
Other reconciling items, net	95	4	260	9
Non-GAAP Adjusted EBITDA	117,286	112,188	367,202	375,907
Employee Stock Purchase Plan (ESPP)
Segment Reporting Information [Line Items]
Stock-based compensation	100	100	500	400
Operating Segments | Supply Chain Services
Segment Reporting Information [Line Items]
Non-GAAP Adjusted EBITDA	122,040	118,034	371,228	381,586
Operating Segments | Performance Services
Segment Reporting Information [Line Items]
Non-GAAP Adjusted EBITDA	25,018	26,552	87,587	89,277
Corporate
Segment Reporting Information [Line Items]
Non-GAAP Adjusted EBITDA	$ (29,772)	$ (32,398)	$ (91,613)	$ (94,956)